89th Annual MeetingGLASGOW SECC 7th – 10th July 2009

British Association of Dermatologists

Final Programme

GLA

SGO

W 2

009

ELIDEL®:Tough on eczema,

not on skin

In mild to moderate eczema where topical steroids can be a problem,1

ELIDEL® delivers rapid relief from itch.2 ELIDEL®’s low potential to cause skin atrophy3 means it can be used on sensitive face and neck areas in both adults and children over two years old.1

UK Abbreviated Prescribing Information. Elidel® 1% cream (pimecrolimus). Please refer to the ELIDEL®

Summary of Product Characteristics for full prescribing information. Presentation: Whitish, homogenouscream containing 1% w/w pimecrolimus. Indications: Mild or moderate atopic dermatitis (eczema) inpatients aged 2 years and over where treatment with topical corticosteroids is either inadvisable or notpossible: short-term treatment of signs and symptoms of atopic dermatitis and long-term intermittenttreatment for prevention of progression to flares. Dosage and administration: ELIDEL cream should beinitiated by physicians experienced in the treatment of atopic dermatitis. Discontinue if no improvement after6 weeks or disease exacerbation. Adults and children aged 2 years and over: apply a thin layer of cream tothe affected skin twice daily. Rub in gently and completely. Continue until signs and symptoms have resolved,then discontinue. ELIDEL cream may be used on all skin areas, excluding mucous membranes. For long-term intermittent treatment, apply at first signs and symptoms to prevent progression to flares. Continue untilsigns and symptoms have resolved, then discontinue. Treatment should be intermittent, short-term and notcontinuous. Emollients can be applied immediately after using ELIDEL cream. Elderly patients: clinical studiesdid not include sufficient numbers of patients aged 65 years and over to determine whether they responddifferently from younger patients. Contraindications: Hypersensitivity to pimecrolimus, other macrolactamsor excipients of ELIDEL cream. Precautions: May cause mild and transient application site reactions e.g.warmth and/or burning sensation. Avoid contact with eyes and mucous membranes. If accidentally appliedto these areas, cream should be thoroughly wiped and/or rinsed off with water. Contains cetyl alcohol, stearylalcohol and propylene glycol, which may cause skin reactions/irritation. ELIDEL should not be used inpatients with congenital or acquired immunodeficiencies or in patients on therapy that causesimmunosuppression. Do not use concomitantly with topical corticosteroids or other anti-inflammatoryproducts. Cases of malignancy, including cutaneous and other types of lymphoma, and skin cancers havebeen reported. However, patients with atopic dermatitis treated with ELIDEL have not been found to havesignificant systemic pimecrolimus levels. Long-term effect on the local skin immune response and on theincidence of skin malignancies is unknown. ELIDEL should not be applied to potentially malignant or pre-malignant skin lesions, or to areas affected by acute cutaneous viral infections (herpes simplex, chicken pox).Clear infections at treatment sites before application. Increased risk of herpes simplex virus skin infection andeczema herpeticum. If herpes simplex virus skin infection develops, discontinued ELIDEL until the infectionhas cleared. Increased risk of skin bacterial infections (impetigo) in patients with severe atopic dermatitis.

Not recommended in patients with erythroderma or Netherton’s syndrome. Do not apply under occlusivedressings. Not recommended during pregnancy or breast feeding. In patients with extensive disease,administer vaccinations during treatment-free intervals. Avoid excessive exposure of skin to ultraviolet light.Avoid therapy with PUVA, UVA or UVB during treatment. Undesirable effects: Application site reactionsreported by 19% of ELIDEL patients and 16% of patients in the control groups. These reactions generallyoccurred early in treatment, were mild/moderate and of short duration. Very common (≥1/10): application siteburning. Common (≥1/100, <1/10): application site reactions (irritation, pruritus, erythema), skin infections(folliculitis). Uncommon (≥1/1,000, <1/100): furuncle, impetigo, herpes simplex, herpes zoster, herpessimplex dermatitis (eczema herpeticum), molluscum contagiosum, skin papilloma, application site disorderssuch as rash, pain, paraesthesia, desquamation, dryness, oedema, and condition aggravated. Quantitiesand basic NHS price (excl. VAT): 30g tube, £19.69; 60g tube, £37.41; 100g tube, £59.07. Marketingauthorisation number: PL 0010/0659. ® denotes registered trademark. Legal category: POM. Fullprescribing information is available on request from: Novartis Pharmaceuticals UK Ltd., Frimley BusinessPark, Frimley, Camberley, Surrey GU16 7SR. Telephone (01276) 698370. Fax (01276) 698449. Date ofpreparation: 10th September 2007.

References:1. ELIDEL® SmPC. Novartis Pharmaceuticals UK Limited. 2. Meurer M, Fartasch M, Albrecht G, et al. Dermatol 2004;208:365–372. 3. Queille-Roussel C, Paul C, Duteil L, et al. Br J Dermatol 2001;144:507–513.

Date of preparation: January 2009.ELI08000007

Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.gov.uk.

Adverse events should also be reported to Novartis (01276) 698370

FOR01JO8004_A4_Ad_V2_AW:210x297 20/1/09 10:04 Page 1

INDEX PAGE NUMBER

Accommodation 6 - 7

Accompanying persons 8

Additional meetings 48

Badges 8

Banking 8

Business services 8

Catering 8

Certificates of attendance 8

Childminding / babysitting 8

Cloakroom 8

Committee meetings 15

Continuing Professional Development (CPD) 8

Exhibition 8

Exhibition plan 13

Exhibition quiz 8

First aid 9

Lunchtime focus sessions 9

Map of Glasgow 58

Meetings calendar 59

Messages 9

Organising committees 4

Parking 9

Patient support groups 9

Payment of registration fees 9

Poster exhibition 9

Posters 49 - 54

Registration desk 10

Restaurants 10

Satellite symposia 55 - 57

Social events 14

Speaker preview 10

Special interest groups 10

Sporting activities 14

Transport - to and from Glasgow 10 - 11

Venue plan 12

Welcome to Glasgow 5

IND

EX

3

PAGE NUMBERPROGRAMMES

Programme index 16

MONDAy OvERvIEw 17

DermSchool 18

Trainee pre-conference session 19

SAS Session 20

TUESDAy OvERvIEw 21

Clinico-pathological cases - Joint BAD / BSD 22 - 23

Lunchtime Focus Sessions 23 - 24

Plenary Session 24

Guest Lecture 1 24

Guest Lecture 2 24

British Contact Dermatitis Society (BCDS) 26 - 27

British Society for Dermatopathology (BSD) 28 - 29

British Society for Dermatological Surgery (BSDS) including BCDG joint section 2 30 - 32

wEDNESDAy OvERvIEw 33

Plenary Session 34 - 35

Guest Lecture 3 34

British Society for Paediatric Dermatology (BSPD) 36 - 37

ThURSDAy OvERvIEw 39

Professor’s & Registrars’ Forum 40

Guest Lecture 4 41

Lunchtime Focus Sessions 41

BAD and BDNG Joint Meeting 41 - 42

Historical 43

British Photodermatology Group (BPG) 44 - 45

FRIDAy OvERvIEw 46

CPD Update 47

Guest Lecture 5 47

CONFERENCE & EvENT SERvICESMr Christopher Garrett - Conference & Event Services Manager

Mrs Marie Elwér – Finance and Conference AdministratorMiss Giuliana Vittiglio – Events Coordinator

Miss Jenna Sanders – Conference and Events Assistant

British Association of Dermatologists4 Fitzroy Square

London W1T 5HQTel: +44 (0)20 7391 6358Fax: +44 (020 7388 0487

Email: conference@bad.org.uk

ORGANISING COMMITTEEDr Alex Anstey

Dr Clive Archer - ChairMiss Marilyn Benham

Dr David EedyMr Christopher Garrett

Dr Mark Goodfield Dr Stephen Jones Dr Jane McGregor

SCIENTIFIC COMMITTEEDr Clive Archer - Chair

Dr David EedyDr Claire Fuller

Professor David GawkrodgerDr Mark GoodfieldDr Stephen JonesDr Graham Ogg

Dr Rob Sheehan-DareDr Maureen Walsh

JUDGING COMMITTEEDr Malcolm Rustin - Chair

Dr Mike Arden-JonesDr David de Berker

Dr Ian CoulsonDr Sally IbbotsonDr Richard LoganDr Sandy McBride

Dr David PaigeDr John Reed

ACKNOwLEDGEMENTSThe British Association of Dermatologists gratefully acknowledges the contribution of the many

exhibitors & sponsors whose attendance has helped make the meeting possible.

4

OR

GA

NIS

ING

CO

MM

ITT

EE

A wARM wELCOME TO GLASGOw 2009We are very pleased to be holding the 89th Annual Meeting of the BAD in the city of Glasgow. Glasgow is an exciting and vibrant city, famous for its industrial, seafaring, artistic and musical heritage, as well as its impressive historical and modern architectural traditions. The cultural capital of Scotland, Glasgow sits on the banks of the River Clyde and is surrounded by fine seascapes and beautiful countryside.

The conference will be held in the Scottish Exhibition and Conference Centre (SECC). Situated only 5 minutes drive away from Glasgow City Centre; the SECC is superbly built and brilliantly equipped for another successful BAD conference.

SCIENTIFIC PROGRAMME

The BAD is proud of the reputation of our annual meeting. The annual meeting committee has worked hard to provide a blend of new scientific presentations with updates from experts in various formats.

The Arthur Rook Oration this year will be delivered on Thursday by Professor Donald Leung, from Denver, USA, an international authority on the ‘Immunology of Atopic Dermatitis’. Professor Judy Breuer from London will open the guest lectures on Tuesday with a talk on ‘VZV and the skin’. She will be followed later that afternoon by Professor Filippa Nyberg from Stockholm presenting on ‘Gender and Autoimmune Diseases’. Wednesday programme will include Professor Paul Emery from Leeds addressing the audience on ‘The future of Biological Therapies in Rheumatology’, with talks from Professor Andrew Lister (Bristol) on ‘The risks and benefits of exposure to sunlight’ and Dr Ray Fox (Glasgow) on ‘HIV and the skin’. On the final day there will be guest lectures from Professor Kenneth Calman on ‘Medical education: Past. Present and future’ providing a local flavour, followed by Professor Christopher Zachary from Irvine, USA on ‘What’s new in Cosmetic Dermatology’ to conclude what promises to be a memorable meeting.

Medical dermatology features strongly in the programme with a dedicated session on Wednesday afternoon. The Wednesday Satellite Symposium slots will continue as will the poster viewing slot after the AGM on the Thursday morning. In response to feedback from the 2008 meeting we have four focus sessions on the Tuesday and Thursday lunchtimes. Please note however that these must be pre-booked, so sign up early to avoid disappointment. We shall again finish with the CPD session and I am very grateful to those invited speakers for sharing their expertise.

Our colleagues from the British Dermatological Nursing Group (BDNG) will have a busy academic programme in parallel with the BAD meeting and will join us for the Joint session on Thursday.This year also sees the launch of DermSchool, the BAD’s annual course for medical students and foundation year doctors, with a hundred registrants from all over the UK.

SOCIAL PROGRAMMEThe President’s Reception will be held at the Glasgow Science Centre, Scotland’s biggest Millennium Project, situated in the heart of Glasgow on the banks of the river Clyde. With its striking titanium clad structures it features an Imax theatre, the Glasgow tower and the Science Mall. The centre aims to showcase Scotland’s contribution to science and technology, past present and future. The Glasgow Science Centre is a five minute walk from the SECC across the river Clyde.

The Annual Dinner will be held at the Kelvingrove Art Gallery, an impressive building set in the beautiful surroundings of Kelvingrove Park. The Gallery was re-opened in 2006 after a £28 million refurbishment and is the most visited museum and art gallery in the United Kingdom outside London. Kelvingrove Art Gallery houses over 8000 exhibits and has one of Europe’s finest civic art collections.

Enjoy the meeting!

Clive ArcherAcademic vice President (2007-2009)

wELC

OM

E

5

6

AC

CO

MM

OD

AT

ION

89th Annual Meeting of the British Association of Dermatologists & the 19th British Dermatological Nursing Group Annual Meeting

Glasgow, SECC, 7th – 10th July 2009

Mapref.

Accommodation Star rating Car Parking Leisure Single room rate

Double/Twin room rate based on 2 sharing

1 Crowne Plaza 4 Onsite Yes £150 £160

2 City Inn 3 Onsite No £140 £150

3 Campanile Hotel 3 Onsite No £86 £92

4 Hilton Glasgow 5 Onsite Yes £155 £165

5 Radisson SAS 5 Nearby Yes £150 £160 6 Glasgow Marriott 4 Onsite Yes £120 £130

7 Fraser Suites (light breakfast) 4 Nearby No £120 £140

8 Menzies Hotel 4 Onsite Yes £120 £130

9 Millennium Hotel 4 Nearby No £130 £140

10 Park Inn 4 Nearby No £130 £140

11 Jury’s Inn 3 Nearby No £100 £120

12 Novotel 3 Nearby No £115 £125

13 Premier Inn Argyle Street 3 Nearby No £83.50 £91

14 Premier Inn George Square 3 Nearby No £72.50 £100

* Please note the rates above include a full Scottish breakfast and VAT unless otherwise stated.

Scottish Exhibition & Conference Centre

A

A

Venue reference key

Page 2 / 2

89th Annual Meeting of the British Association of Dermatologists & the 19th British Dermatological Nursing Group Annual Meeting

Glasgow, SECC, 7th – 10th July 2009

Mapref.

Accommodation Star rating Car Parking Leisure Single room rate

Double/Twin room rate based on 2 sharing

1 Crowne Plaza 4 Onsite Yes £150 £160

2 City Inn 3 Onsite No £140 £150

3 Campanile Hotel 3 Onsite No £86 £92

4 Hilton Glasgow 5 Onsite Yes £155 £165

5 Radisson SAS 5 Nearby Yes £150 £160 6 Glasgow Marriott 4 Onsite Yes £120 £130

7 Fraser Suites (light breakfast) 4 Nearby No £120 £140

8 Menzies Hotel 4 Onsite Yes £120 £130

9 Millennium Hotel 4 Nearby No £130 £140

10 Park Inn 4 Nearby No £130 £140

11 Jury’s Inn 3 Nearby No £100 £120

12 Novotel 3 Nearby No £115 £125

13 Premier Inn Argyle Street 3 Nearby No £83.50 £91

14 Premier Inn George Square 3 Nearby No £72.50 £100

* Please note the rates above include a full Scottish breakfast and VAT unless otherwise stated.

Scottish Exhibition & Conference Centre

A

A

Venue reference key

Page 2 / 2

ACCOMMODATION

AC

CO

MM

OD

AT

ION

7

ACCOMMODATION BOOKING FORM

89th Annual Meeting of the British Association of Dermatologists & the 19th British Dermatological Nursing Group Annual Meeting Glasgow, SECC, 7th – 10th July 2009

PLEASE COMPLETE IN BLOCK CAPITALS

LEAD NAME:

Title, Surname, Forename SHARING WITH:

COMPANY:

ADDRESS:

EMAIL:

DAY TIME TEL NO: ___________________________ FAX NO: _______________________________

ARRIVAL DATE: _________________ DEPARTURE DATE: ________________ NO. OF NIGHTS: ___________

SINGLE ROOM (1 PERSON, 1 BED) DOUBLE ROOM (2 PEOPLE, 1 BED) TWIN ROOM (2 PEOPLE, 2 BEDS)

PREFERRED ACCOMMODATION (see overleaf for details):

1st Choice: _______________________ ____2nd Choice: ____ ____ ___ ______ 3rd Choice: __ __ ___ __________

SPECIAL REQUIREMENTS (e.g. non-smoking): ______ _____________ ______ ________________________________Please note that these are requests and cannot be guaranteed.

Please accept my credit card to guarantee the reservation: Visa / Mastercard / Maestro/Switch. In the event of non-arrival or late cancellation terms and conditions will apply.

CARD NUMBER: EXPIRY DATE: CARD ISSUE NO (if applicable): NAME ON CARD:

Signature: _____________________________________________ Date: ____________________________A guarantee of payment is required in order for the booking to be processed

Please return completed form to the address below by 25th May 2009, otherwise availability and conference rates cannot be guaranteed. Terms and ConditionsNon-arrivals or failure to cancel a reservation within the cancellation terms and conditions may incur charges. INDIVIDUAL BOOKINGS TO 2 ROOMS: Cancellations can be made up to 48 hours prior to arrival without penalty. Cancellations of all or any room nights after the 48hour deadline will incur 100% charges.3 TO 5 ROOMS: Cancellations can be made up to two weeks prior to the start date of the conference. Cancellations of all or any room nights after this date will incur 100% charges.6 TO 9 ROOMS: Cancellations can be made up to three weeks prior to the start date of the conference. Cancellations of all or any room nights after this date will incur 100% charges.For bookings of ten or more rooms you may be required to contract direct with the hotel.

Glasgow City Marketing Bureau acts only as an agent for hotels and other accommodation units and does not contract as a principal.Accordingly, we shall not be liable for any loss or damage due to or arising from any acts or omissions of persons, firms or companies for whom we act as agents. Further, we shall in no event be liable for any loss of profit or consequential loss or damage due to or arising from negligence on the part of Glasgow City Marketing Bureau or its servants, agents or subcontractors. We shall not be liable to any extent in the event of delay or failure in providing or procuring any services or facilities due to any cause beyond the proper control. The Bureau acts as an intermediary in securing accommodation and cannot accept any responsibility for standards of the accommodationproviders.

Accommodation Booking Service, Glasgow City Marketing Bureau, 11 George Square, Glasgow G2 1DY Tel: +44 (0) 141 566 0822 or +44 (0) 141 566 0820, Fax: +44 (0) 141 566 0810, Email: accommodation@seeglasgow.com

To book on-line please visit https://www.conferencebookings.co.uk and use the event reference: GMBBADBDNG09 Please note - no telephone bookings, enquiries welcome

Page 1 / 2

ACCOMMODATION

8

DEL

EGA

TE

INFO

RM

AT

ION

A –

ZACCOMPANYING PERSONSIf you would like to book a place on either of the accompanying persons’ tours please complete the relevant section of the registration form.

Tuesday 7th July, 14:00 – 17:00Fee – £20Glasgow City TourA visit to the Burrell Collection, one of the greatest art collections created by one person, William Burrell. Then on for a tour of the Kelvingrove Museum, a spectacular red sandstone building which accommodates over 8000 objects.

wednesday 8th July, 09:30 – 17:00Fee – £40 (lunch and tour included)Edinburgh TourA panoramic tour of Edinburgh, one of the most vibrant, cosmopolitan cities in Europe, taking in the stunning Georgian and Victorian architecture. Followed by a well deserved break for lunch in the centre of the city. Then on for a guided tour of Edinburgh Castle, a spectacular site with over one thousand years of history.

we regret that neither accompanying persons nor children/babies are permitted entrance to the exhibition areas.

BADGESConference badges will be handed to delegates on registration. For security purposes name badges must be worn at all times throughout the meeting. In the event that you lose your badge, a replacement must be obtained at the registration desk immediately.

BANKINGA Bank of Scotland banking lobby is located on the east concourse (between the Box Office and Loch Suite) and offers an ATM service. In addition to Bank of Scotland cashline cards, the ATM also services the following: Amex, Barclays, Clydesdale, CIRRUS, EC, EuroMasterCard, Link, Lloyds TSB, Maestro, Mastercard, NatWest, PLUS, Royal Bank of Scotland, VISA.

BUSINESS SERVICESThe business centre is located on the Concourse along from the East entrance and offers a comprehensive range of business services including sending and receiving faxes, photocopying and internet access. The Business Services fax no. is 0141 576 3224.

CATERINGLunch and all scheduled refreshment breaks will be served from designated points in exhibition hall 5 of the Scottish Exhibition and Conference Centre. If the nearest catering point is not open, staff will direct you to the next most convenient point.

CERTIFICATES OF ATTENDANCECertificates of attendance will automatically be sent to all attendees after the meeting.

CHILDMINDING / BABYSITTINGThere will be no crèche facilities at the meeting. Please approach your hotel directly for a babysitting service or to make alternative child care arrangements. Please note that babies and children cannot be admitted to the exhibition areas or social events.

CLOAKROOMThe cloakroom will be located in the Clyde Foyer at the SECC (opposite registration). There will be a charge of £1 per item. Guests will also be able to store luggage on the day of departure.

COMMITTEE MEETINGSA programme of the scheduled committee meetings can be found on page 15.

CONTINUING PROFESSIONAL DEVELOPMENT CREDITS (CPD)This event has been approved for 24 External credits for the CPD Scheme of the Federation of Royal Colleges of Physicians of the UK. Code 49768. Physicians should record their credits in their diaries, in accordance with the current RCP recommendations. Participants should only record the number of hours they attended.

EXHIBITIONThe exhibition will be located in Hall 5 of the SECC and will be open at the following times:Tuesday 7th July 08:30 – 17:30 Wednesday 8th July 08:30 – 17:30Thursday 9th July 08:30 – 16:00

EXHIBITION QUIZExhibition quiz forms will be included in delegate bags. To participate in the quiz, delegates must visit each participating exhibitor and answer a simple question. Participants must also obtain 4 answers from the patient support groups, please note you only need 4 from any of the Patient Support Groups present over the duration of the meeting. All completed registration forms must be returned to the registration desk by 14:00 on Thursday 9th July. The prize winners will be announced at the annual dinner later that evening.

EXHIBITORSPlease see page 13 for a full list of exhibitors and an exhibition plan.

FIRST AIDThe First Aid Suite is situated at the east end of the concourse and will be staffed by the SECC.

LUNCHTIME FOCUS SESSIONS*- All 13:10 – 13:55Free of charge and including lunch bag.

* Limited places available. Please reserve your place using the registration form. Tuesday 7th July• Cancer peer review – Panel Discussion• Clinical excellence awards process

– Colin Holden & Jane Sterling• Laser update – Richard Barlow• Psychodermatology – Anthony Bewley

Thursday 9th July• Clinical service issues – Panel Discussion• Common & rare tropical diseases that

shouldn’t be missed – Rachel Morris-Jones• Surgical pearls – Catriona Irvine & Richard Motley• Neo-natal dermatology you can’t afford

to miss – Cameron Kennedy & Lindsay Shaw

MESSAGESA delegate notice board will be situated adjacent to the registration desk, where all delegates’ messages will be displayed.

PARKINGOn-site parking is available for over 2,500 vehicles at £5.00 per car per visit.

PATIENT SUPPORT GROUPSThe following patient support groups will be represented at the meeting and will have stands in the exhibition hall:

Name Date (s) Allergy UK Weds July 8th British Association of Skin Tues July 7th, Weds Camouflage July 8th & Thurs July 9thBritish Red Cross Tues July 7th, Weds July 8th & Thurs July 9thCommunity Dermatology Tues July 7th, Weds July Journal 8th & Thurs July 9thDystrophic Epidermolysis Tues July 7th, Weds Bullosa Research July 8th & Thurs July 9th AssociationEhlers-Danlos Support Wed 8th July Group Gorlin Syndrome Group Tues July 7th & Weds July 8th Ichthyosis Support Group Tues July 7th, Weds July 8th & Thurs July 9th

Latex Allergy Support Weds July 8th & Thurs Group July 9thMelanoma Support Tues July 7th, Weds July - Scotland 8th & Thurs July 9thNational Eczema Society Tues July 7th & Weds July 8th NHS Evidence Tues July 7th, Weds July - skin disorders 8th & Thurs July 9thPsoriasis Scotand Arthritis Tues July 7th, Weds July Link Volunteers (PSALV) 8th & Thurs July 9thSkcin Tues July 7th, Weds July 8th & Thurs July 9thSkin Camouflage Tues July 7th, Weds July Network 8th & Thurs July 9thSkin Care Campaign Tues July 7th, Weds July Scotland 8th & Thurs July 9thThe Hyperhidrosis Tues July 7th, Weds July Support Group 8th & Thurs July 9thThe Psoriasis Association Tues July 7th, Weds July 8th & Thurs July 9thThe Scleroderma Society Weds July 8th & Thurs July 9thThe Vitiligo Society Tues July 7th & Weds July 8th UK Dermatology Tues July 7th, Weds July Clinical Trials Network 8th & Thurs July 9thXeroderma Pigmentosum Weds July 8th & Thurs Support Group July 9th

In addition, the following groups will have stands within the exhibition area:British Journal of Dermatology / CEDBritish Dermatological Nursing GroupHistorical CollectionBAD Media & Communication AdviceBritish Skin FoundationBADBIR

PAYMENT OF REGISTRATION FEESWe would prefer delegates to pay by cheque (pounds sterling drawn on a UK bank only or by sterling bank draft) made payable to the ‘British Association of Dermatologists’. Cheques in other currencies cannot be accepted. Alternatively, delegates may pay by credit card and this is encouraged for overseas delegates. Please note that we only accept MasterCard and Visa. American Express cannot be accepted.

POSTER EXHIBITIONThe poster exhibition will be located within Hall 5 of the SECC. The posters will be numbered and a list is provided at the back of this programme.

Posters should measure a maximum of 1.5m high x 1m wide (portrait) and must be mounted with

DELEG

AT

E INFO

RM

AT

ION

A – Z

9

Velcro. Presenters will be able to mount their posters from 08:30 on Tuesday 7th July. Posters should not be removed until 16:00 on Thursday 9th July. Please note that the British Association of Dermatologists cannot be held responsible for any loss or damage to a poster presented during the Annual Meeting. There will be a dedicated poster viewing session on wednesday 8th July 10.30 - 11.30.

REGISTRATION DESK The registration desk will be located in the SECC Clyde Foyer area and will be staffed by the BAD team during the following hours:

Monday 6th July 11:00 – 18:00Tuesday 7th - Thurs 9th July 08:00 – 18:00Friday 10th July 08:30 – 12:00

Telephone number 0141 5763587.

RESTAURANTSAt the SECCThe Gallery Bistro at the SECC offers a full a la carte menu and daily specials. The restaurant is open daily until 16:30. To book a table call 0141 576 3118.Caffe Ritazza at the SECC is situated on the main concourse and offers speciality coffees, a full range of savoury bread lines, ciabattas, toasted paninis and flat sandwiches, plus a wide range of sweet pastries.

LocalUbiqutous Chip, Tel: 0141 334 500712 Ashton LaneLa Fiorentina, Ristorante, Tel: 0141 420 1585 2 Paisley Road WestGamba, Tel: 0141 572 0899 225a West George StreetLa Bonne Auberge, Tel: 0141 352 8310 161 West Nile StreetCafé Gandolfi, Tel: 0141 552 6813 64 Albion StreetMalmaison, Tel: 0141 572 1002 278 West George Street

SATELLITE SYMPOSIAThe following companies will be holding satellite symposia at the meeting:

Tuesday 7th July17:30 – 18:30 LEO PhARMA wednesday 8th July 13:00 – 14:00 ABBOTT13:00 – 14:00 STIEFEL 13:00 – 14:00 JANSSEN CILAG18:00 – 19:00 SChERING PLOUGh

Thursday 9th July17:30 – 18:30 ASTELLAS

SOCIAL EVENTSPlease see Social Programme (Page 14).

SPEAKER PREVIEWSpeaker preview will be located in Gala 2 Room on the upper level Clyde foyer at the SECC, please ask at the registration desk for directions. All presenters must take their disks to speaker preview at least two hours prior to their presentation. Data projection (PowerPoint) will be available.

SPECIAL INTEREST GROUPSThe following Special Interest Groups will hold their meetings during the week of the conference. All special interest group meetings will take place at the SECC. Their full programmes are featured at the back of each days full programme.

Tuesday 7th July British Contact Dermatitis Society 09:30 – 13:00 (Page 26 – 27)

British Society for Dermatopathology 13:30 – 17:00 (Page 28 – 29)

British Society for Dermatological Surgery 14:00 – 17:00 (Page 30 - 32) British Cosmetic Dermatology Group 15:40 – 16:22 (Page 30 - 31)

wednesday 8th JulyBritish Society for Paediatric Dermatology 14:00 – 17:15 (Page 36 – 37)

Thursday 9th JulyHistorical 13:00 – 14:00 (Page 43)

British Photodermatology Group 14:30 – 17:15 (Page 44 – 45)

TAXISGlasgow Premier Taxi Company Tel: 0141 429 7070

TRAVEL

GETTING TO GLASGOW

By Rail

Glasgow has the largest rail network in the UK outside London. Glasgow’s Central Station is connected with every city in the UK, while Queen Street Station

10

DEL

EGA

TE

INFO

RM

AT

ION

A –

Z

serves central and northern Scotland. Call National Rail Enquiries on 0845 7484950. Once you’re in Glasgow, your journey right to the venue front door can be completed by train. Trains run to the SECC from the city centre with a journey time of just three minutes.

By Coach

Coach operators run services to Glasgow’s Buchanan Bus Station from throughout the UK.

By Road

SECC is just off junction 19 of the M8 motorway. On-site parking is available for over 2,500 vehicles at £5.00 per car per visit.

By Air

Glasgow is served by three international airports, Glasgow International, Glasgow Prestwick and Edinburgh International.Glasgow’s International Airport is less than 15 minutes drive by direct motorway link from the city centre

From the airport, First Bus 757 service operates daily (every 20 minutes) to Glasgow City Centre via the SECC and return.

FROM WITHIN GLASGOWSituated just off junction 19 of the M8 motorway, the SECC is within five minutes drive of the city centre and 15 minutes from Glasgow International Airport. SECC has its own railway station and bus terminal linking with Glasgow’s excellent public transport system.

By Bus

From the airport, First Bus 757 service operates daily (every 20 minutes) to Glasgow City Centre via the SECC and return.

By Train

Exhibition Centre station is SECC’s own dedicated railway station allowing easy access from the city centre and the suburbs. Six trains an hour from Central Station (Platform 15) will bring you to Exhibition Centre station in a journey time of just three minutes.

Call National Rail Enquiries on 08457 48 49 50 for timetable and price details.

By Road

SECC is just off Junction 19 of the M8 motorway. from the M8 take the westbound Clydeside Expressway (A8414). Exit at ‘SECC West’ slip to access our car parking facilities, with space for over 2,500 cars. Parking is £5.00 per car, per visit.

By Taxi

There are taxi ranks throughout the city. Main pick-up points include Buchanan Bus Station, Queen Street and Central Stations and most large hotels.

An average journey from the city centre will cost around £5.00.

VENUEScottish Exhibition and Conference Centre (SECC)GlasgowG3 8YW

Tel: +44 (0) 141 248 3000Fax: +44 (0) 141 226 3423

www.secc.co.uk

DELEG

AT

E INFO

RM

AT

ION

A – Z

11

12

vEN

UE

PLA

N

The Scottish Exhibition

& Conference Centre

(SECC)

Clyde Forth

Registration Speaker Preview

Exhibition Posters Catering

Carron Dochart

Alsh Boisdale Lomond

Etive Fyne

Leven Ness

Morar

The Scottish Exhibition & Conference Centre(SECC)

EXh

IBIT

ION

PLA

N

13

Exhibition Plan

SOCIAL EvENTS

PRESIDENTS’ RECEPTIONGlasgow Science Centre Tuesday 7th July 18:45

The Presidents’ Reception will be held in the Science Mall at the Glasgow Science Centre, situated in the heart of Glasgow on the banks of the river Clyde. A five minute walk from the SECC, the Science Centre aims to showcase Glasgow’s contribution to science and technology. The Science Mall, a gleaming, striking titanium clad structure overlooking the Clyde River, is packed with hundreds of interactive exhibits. The reception is to be held amongst the hands-on interactive displays and guests will be free to walk around the centre and try out the exhibits. Drinks and canapés will be served from 18:45 onwards.

BRITISh SKIN FOUNDATION wALKStarting point SECC Wednesday 8th July 17:45 for 18:00 start

This years BAD sponsored Walk will begin from the SECC. The walk will be approximately 4 miles long and is planned to display points of interest along the Clyde. The sponsored walk will be followed by drinks and supper at the Crown Plaza provided by walk supporters LEO Pharma and Dermal Laboratories. Come and walk with us for some mid-conference exercise and a wonderful tour of the city, as well as great fun and food all in support of British Skin Foundation funded skin disease research.

ANNUAL DINNERKelvingrove Art Gallery and Museum Thursday 9th July 19:30

The Annual Dinner and Dance will be held in the Kelvingrove Art Gallery and Museum, a striking red sandstone building set in the beautiful surroundings of Kelvingrove Park. The gallery, located on the banks of the River Kelvin, was re-opened in 2006 after a £28 million refurbishment and is the most visited museum and art gallery in the United Kingdom outside London. The Art Gallery houses over 8000 exhibits and has one of Europe’s finest civic art collections. The Kelvingrove will be a memorable and beautiful venue for the BAD’s Annual Dinner, an event which is certainly not to be missed!

SPORTS ACTIvITIES

wednesday 8th July All sports events will be held at venues in and around the city on Wednesday afternoon. The departure point for all events will be from outside the SECC.

Bowers-Sneddon-harman Sailing Competition - 18:00The sailing competition will take place at SailLaser Scotland within Strathclyde Country Park, within a purpose built Water sports centre on a vast 400 acre loch. Limited places will be available and people should bring warm layers and waterproofs. Full details of the event will be sent following registration.

Dowling – McCaw Golf Cup – 15:00The golf tournament is being held at the Pollok Golf Club located in the heart of Pollok Country Park, home of the internationally renowned Burrell Gallery. After undergoing a £1.2 million refurbishment the clubhouse is now one of the finest in Scotland. Please note that Green fees will be charged per person and the tournament will be followed by a meal at the Club. Full details of the event will be sent following registration. Five-a-side Football – 18:00The competition will be held at the Scotstoun Leisure Centre in the West-End of Glasgow. The competition is open to everyone, members, non-members, guests and exhibitors. You may apply as a team or individually.

Ive Piscatorial (Fishing) CompetitionThe Ive Piscatorial Award will be held at the Howwood Fishery. Further details of the event will be sent following registration.

Tennis – 18:00The tennis competition will take place outdoors at the Scotstoun Leisure Centre in the West-End of Glasgow. In the event of bad weather please visit the registration desk well in advance. Participants should bring their own racquets and proper tennis shoes are required.

14

SOC

IAL

PR

OG

RA

MM

E

Kelvingrove Art Gallery & Museum – Annual Dinner venue

CO

MM

ITT

EE MEET

ING

S

15

MEETINGS Mon 6th JuLY TIME MEETING ROOM

16:00 – 18:00 British Association of Dermatologists Officers Ness18:00 – 19:00 National Speciality Trainee Committee Katrine18:10 – 18:45 Post DermSchool Meeting Forth

TUES 7Th JULy TIME MEETING ROOM

08:00 – 09:30 British Society for Dermatopathology Exec Committee Ness09:00 – 09:30 British Contact Dermatitis Society AGM Forth11:00 – 14:00 British Society for Dermatological Surgery Committee Ness11:30 – 13:00 British Skin Foundation Trustees Leven13:00 – 13:45 British Cosmetic Dermatology Group AGM Carron13:00 – 15:00 Community Dermatology Editorial Board Morar13:30 – 14:00 British Society for Dermatopathology AGM Lomond14:30 – 16:30 Clinical Services Committee Leven14:30 – 16:30 Biologics Steering Committee Ness16:00 – 17:00 Audit & Clinical Standards Etive16:30 – 17:30 Biologics Management Committee Ness17:00 – 17:30 British Society for Dermatological Surgery AGM Forth 17:00 – 18:00 Therapy & Guidelines Etive17:30 – 18:30 Dermatology Teachers Leven17:30 – 18:30 BAD Session Judging Committee Fyne

wED 8Th JULy TIME MEETING ROOM

08:30 – 10:30 British Association of Dermatologists’ AGM (Members Only) Clyde 10:30 – 11:30 British Society for Paediatric Dermatology Training Committee Fyne13:00 – 15:00 Welsh Council Ness14:00 – 16:00 British Journal of Dermatology Morar14:00 – 16:00 Health Informatics Etive14:30 – 16:30 British Association of Dermatologists Officers Leven17:00 – 19:30 Senior Skin Group Dochart 117:30 – 18:30 BAD Session Judging Committee Morar17:30 – 18:00 UK Professors Group Carron 218:00 – 19:00 British Society for Paediatric Dermatology Committee Carron 1

ThURS 9Th JULy TIME MEETING ROOM

08:30 – 09:30 Exhibitors’ Meeting Morar08:30 – 10:30 British Skin Foundation Grants Advisory Fyne10:00 – 11:30 International Investigative Dermatology 2013 Committee Ness10:30 – 13:00 British Photodermatology Group Committee Etive13:00 – 14:00 Clinical and Experimental Dermatology Editorial Meeting Ness13:00 – 15:00 BAD Session Judging Committee Fyne13:30 – 14:00 British Photodermatology Group AGM Lomond14:00 – 15:00 Historical Collection Sub-Committee Boisdale 114:30 – 16:30 British Association of Dermatologists’ Executive Committee Alsh 114:30 – 16:00 Acne Genetics Steering Group Leven15:30 – 17:00 UK Dermatology Clinical Trials Network Panel Meeting Morar17:00 – 18:30 UK Dermatology Clinical Trials Network AGM Ness

16

PR

OG

RA

MM

E IN

DEX

PROGRAMME INDEX PAGE NUMBER

MONDAy Overview 17

DermSchool 18

Trainee pre-conference session 19

SAS Session 20

TUESDAy Overview 21

Clinico-pathological cases - Joint BAD / BSD 22 – 23

Lunchtime Focus Sessions 23 – 24

Plenary 23 - 24

Guest Lecture 1 24

Guest Lecture 2 25

British Contact Dermatitis Society 26 - 27

British Society for Dermatopathology 28 - 29

British Society for Dermatological Surgery 30 - 32

including BCDG joint session 2

wEDNESDAy Overview 33

Plenary 34 - 35

Guest Lecture 3 34

British Society for Paediatric Dermatology 36 - 37

ThURSDAy Overview 39

Professor’s & Registrars’ Forum 40

Guest Lecture 4 41

Lunchtime Focus Sessions 41

BAD and BDNG Joint Meeting 41 – 42

Historical 43

British Photodermatology Group 44 – 45

FRIDAy Overview 46

CPD update 47

Guest Lecture 5 47

Additional meetings 48 Bristol Cup posters 49 – 54 Satellite Symposia 55 – 57

MO

ND

Ay

6T

h JU

Ly – O

vER

vIEw

17

MONDAy 6Th JULy – OvERvIEw

Mo

nd

ay 6

th J

uly

Monday 6

th

July

08

:00

08

:15

0

8:3

0

08

:45

0

9:0

00

9.1

5

09

:30

0

9:4

5

10

:00

10

:15

1

0:3

0

10

:45

11

:00

11

:15

11

:30

11

:45

1

2:0

01

2:1

5

12

:30

1

2:4

5

13

:00

13

:15

1

3:3

0

13

:45

1

4:0

01

4:1

5

14

:30

1

4:4

5

15

:00

15

:15

1

5:3

0

15

:45

1

6:0

01

6:1

5

16

:30

1

6:4

5

17

:00

17

:15

1

7:3

0

17

:45

1

8:0

01

8:1

5

18

:30

1

8:4

5

Cly

de

Au

dit

ori

um

Cly

de F

oyer

Are

a

Hall 5

Fo

rth

Hall 1

Leven

Mo

rar

Ness

Katr

ine

Gala

1

Gala

2

KE

Y

LU

NC

H

14:0

0 -

15:0

015:0

0 -

16:0

017:0

0 -

18:0

0

Tra

inee P

re-c

onfe

rence s

essio

nT

rain

ee P

re-c

onfe

rence s

essio

n

Derm

School

Regis

tration O

pen

Exhib

itio

n B

uild

Up 0

8:0

0 -

21:0

0

Welc

om

e L

unch

08:0

0 -

09:0

09:0

0 -

10.0

0

Derm

School re

g

18:0

0 -

19:0

0

BA

D O

ffic

ers

Meeting

10.0

0 -

11:0

011:0

0 -

12:0

012:0

0 -

13:0

013:0

0 -

14:0

0

Reg B

uild

06:0

0 -

11:0

0

16:0

0 -

17:0

0

SA

S M

eeting

SA

S M

eeting

SA

S R

eg

Changin

g F

aces R

eception

Focus

Sessio

nA

dditio

nal

Gro

ups

Specia

l In

tere

st

Gro

ups

Exhib

itio

n /

Poste

rsB

AD

C

om

mitte

e

Tea / C

offee

Non-B

AD

M

eetings

Sate

llite

S

ym

posia

BA

D

Sessio

ns

BA

D S

taff O

ffic

e

NS

TC

Meeting

Tea

Derm

School

Derm

School m

eeting

Speaker

Pre

vie

w

Dele

gate

In

form

ation

18

MO

ND

Ay

6T

h J

ULy

– D

ETA

ILED

PR

OG

RA

MM

EMONDAy 6Th JULy – DETAILED PROGRAMME TIME CODE PROGRAMME vENUE09:45 – 15:10 BAD DermSchool Course hall 1 Course Organisers: Dr Clive Archer, Dr Jonathan Batchelor,

Dr Ketaki Bhate, Dr Aoife Lally and Dr Minal Singh 09:15 – 09:45 Registration and Coffee Hall 1 09:45 Introduction Dr Clive Archer, Dr Ketaki Bhate and Dr Minal Singh 10:00 DE01 Skin Cancer and Skin Surgery Dr Chris Bower 10:30 DE02 Common Skin Diseases (to incorporate recent advances in

dermatology treatments) • Eczema and Acne Dr Minal Singh • Psoriasis including biologics Dr Aoife Lally • Blistering disorders and other inflammatory dermatoses Dr Stuart Cohen

11:30 DE03 Dermatology for Finals and the MRCP Dr Jonathan Goulding 12:00 Lunch (Group A) / Brymill Cryotherapy Workshop (Group B) 12:40 Brymill Cryotherapy Workshop (Group A) / Lunch (Group B) 13:20 DE04 Research in Dermatology Prof. John McGrath 13:50 DE05 Career paths in Dermatology • How to get into dermatology • Individual, Flexible Training • Career Planning Dr Susannah Baron and Dr Leila El-Dars 14:15 Essay Prize Presentation Dr Zarif Jabbar 14:30 Quiz Dr Adam Bray 14:55 Feedback Session Information on the Student Section of the BAD Dr Ketaki Bhate, Dr Catherine Cook and Dr Clare Bayliss 15:10 Tea DermSchool DELEGATES TO JOIN TRAINEE SESSION NOTE: Posters by DermSchool delegates to be on display in DermSchool meeting room (to include posters by elective prize winners)

18:10 Post DermSchool Meeting Forth

MO

ND

Ay

6T

h JU

Ly – D

ETA

ILED P

RO

GR

AM

ME

19

13:00 – 17:30 Trainee Pre-Conference Session Clyde Course Organisers: Dr David de Berker, Dr Clive Archer,

Dr Jonathan Batchelor and Dr Aoife Lally 12:15 – 13:00 Welcome Lunch Forth 13:00 TPC01 The Specialty Certificate Examination (SCE) Dr Richard Groves 13:30 TPC02 Common hair and Scalp Diseases Dr Martin Wade 14:15 TPC03 Current Management Issues in Dermatology Dr David Shuttleworth 15:00 – 15:30 Coffee Forth 15:30 TPC04 Emergency Dermatology Dr Rachael Morris-Jones 16:15 TPC05 Tropical Dermatology Dr Claire Fuller 17:00 TPC06 The weird and wonderful world of Psychodermatology Dr Richard Staughton 17:45 TPC07 Undergraduate Dermatology Curricula and Teaching Methods Dr Nicole Chiang, Dr Clare Bayliss 18:00 Dowling Club

Dr Dimi Koch

18:10 Session ends

19:00 – 23:00 Trainee & DermSchool Evening event The Tall Ship

20

MO

ND

Ay

6T

h J

ULy

– D

ETA

ILED

PR

OG

RA

MM

E13:00 – 17:35 Staff and Associate Specialists Session Leven A tour of the Special Interest Groups 12:15 – 13:00 Registration Leven Foyer 13:00 welcome & Introduction Dr Glenda Hill 13:05 SAS01 historical Archive Great Dermatologists in history - how many were SAS’s? Dr Nick Levell 13:45 SAS02 Paediatric Dermatology Pearls in paediatric dermatology Dr Sue Lewis-Jones 14:25 SAS03 Contact Dermatitis Iatrogenic contact dermatitis-how much of a problem is it? Dr Mark Wilkinson 15:05 – 15:35 Coffee Morar 15:35 SAS04 Dermatopathology Clinico-pathological correlation of Melanocytic lesions Dr Rob Lister 16:15 SAS05 Dermatological Surgery Top tips and what’s hot and what’s not in dermatological surgery Dr Richard Motley 16:55 SAS06 Photodermatology Phototherapy-now & the future Dr Sally Ibbotson 17:35 Closing remarks 19:00 – 22:00 SAS evening event TBC

TU

ESDA

y 7

Th

JULy

– Ov

ERv

IEw

21

TUESDAy 7Th JULy – OvERvIEw

Tuesday 7

th J

uly

Tuesday 7

th

July

08:0

008:1

5

08:3

0

08:4

5

09:0

009.1

5

09:3

0

09:4

5

10:0

010:1

5

10:3

0

10:4

5

11:0

011:1

5

11:3

0

11:4

5

12:0

012:1

5

12:3

0

12:4

5

13:0

013:1

5

13:3

0

13:4

5

14:0

014:1

5

14:3

0

14:4

5

15:0

015:1

5

15:3

0

15:4

5

16:0

016:1

5

16:3

0

16:4

5

17:0

017:1

5

17:3

0

17:4

5

18:0

018:1

5

18:3

0

18:4

5

Cly

de

Au

dit

ori

um

Cly

de F

oyer

Are

a

Hall 5

Fo

rth

Lo

mo

nd

A

ud

ito

riu

m

Als

h 1

Als

h 2

Bo

isd

ale

1

Bo

isd

ale

2

Carr

on

1

Carr

on

2

Do

ch

art

1

Do

ch

art

2

Eti

ve

Fyn

e

Leven

Mo

rar

Ness

Katr

ine

Gala

1

Gala

2

KE

Y

18:0

0 -

19:0

017:0

0 -

18:0

0

Guest

Lectu

re

Bio

logic

s S

teering C

om

mitte

eB

iolo

gic

s M

anagem

ent C

om

mitte

e

British S

ocie

ty for

Derm

ato

logic

al

Surg

ery

Join

t B

SD

S / B

CD

G

British S

ocie

ty D

erm

ato

path

olo

gy

BS

DS

AG

MB

SD

S

Papers

Exhib

itio

n / P

oste

r

11:0

0 -

12:0

012:0

0 -

13:0

010.0

0 -

11:0

016:0

0 -

17:0

015:0

0 -

16:0

013:0

0 -

14:0

0

Regis

tration O

pen

08:0

0 -

09:0

014:0

0 -

15:0

0

Scie

ntific

Sessio

ns

Scie

ntic S

essio

nG

uest

Lectu

re

9:0

0 -

10.0

0

Lunch B

AD

LF

S04

BS

D A

GM

The V

itili

go S

upport

Gro

up 2

5th

anniv

ers

ary

Derm

ato

logy T

eachers

LE

O P

HA

RM

A S

ate

llite

S

ym

posiu

m

T &

G M

eeting

Exhib

itio

n

BA

D

Sessio

ns

Specia

l In

tere

st

Gro

ups

Exhib

itio

n /

Poste

rsB

AD

C

om

mitte

e

Clin

ical S

erv

ices C

om

mitte

e M

eeting

BS

DS

Com

mitte

e M

eeting

Com

m D

erm

Editorial

Dele

gate

In

form

ation

Clin

icpath

olo

gic

al C

ases

Clin

icpath

olo

gic

al C

ases

Focus

Sessio

nA

dditio

nal

Gro

ups

Non-B

AD

M

eetings

Sate

llite

S

ym

posia

BA

D O

ffic

e

BS

D E

xecutive

BS

F T

ruste

es

Speaker

Pre

vie

w

BC

DS

A

GM

British C

onta

ct D

erm

atitis S

ocie

ty

LF

S02

Azath

ioprine G

uid

elin

e M

eeting

A &

CS

M

eeting

LF

S01

LF

S03

BC

DG

AG

M

Sessio

n J

udges

22

TU

ESD

Ay

7T

h J

ULy

– D

ETA

ILED

PR

OG

RA

MM

ETUESDAy 7Th JULy – DETAILED PROGRAMME TIME CODE PROGRAMME vENUE 08:00 - 18:00 Registration desk open Clyde Foyer

09:30 – 13:00 BRITISh CONTACT DERMATITIS SOCIETy (PAGE 26 – 27) Forth

09:30 – 10:28 CLINICOPAThOLOGICAL CASES Clyde Joint meeting with the British Society of Dermatopathology (page 28 – 29) Chairs: Dr Maureen Walsh and Dr Rob Lister

09:30 CPC01 Effectiveness of methotrexate in oral lichen planus: experience in a specialist oral medicine/dermatology clinic P.D. Yesudian, B.P. Rajlawat and A.E. Field

09:37 CPC02 Subcorneal pustular dermatosis associated with myasthenia gravis

S. Madhogaria, R.S. Muc, A. Huissoon and A.H.M. Heagerty 09:44 CPC03 Adult-onset severe combined immunodeficiency due to Artemis mutation

presenting with a spectrum of mucocutaneous hPv-related disorders N. Attard, K. Gibbon, S. Grigoriadou, R. Cerio and C. Harwood

09:51 CPC04 helios meets Priapus: melanotan II-induced eruptive naevi and

generalized hyperpigmentation J. Shelley, A. Husain and C.M. Lawrence

09:58 CPC05 Efalizumab for the treatment of pityriasis rubra pilaris: experience in

three patients A. Sinha and S. Natarajan

10:05 CPC06 Purple skin lesions and gastrointestinal bleeding: a rare internet

diagnosis V. Madan, E. McMullen and M. Judge

10:12 CPC07 Plasma cell vulvitis: a rare, chronic, inflammatory disease of the

vulva – management of three cases A. Fogo, E. Benton, R. Morris-Jones and E.M. Higgins

10:19 CPC08 Efficacy of isotretinoin for cutaneous manifestations of Muir–Torre

syndrome J. Crawley, M. Walsh and K. Armstrong

10:28 – 11:14 Coffee & Exhibition Hall 5 11:14 – 12:40 CLINICOPAThOLOGICAL CASES CONTINUED... Clyde Chairs: Prof. Rino Cerio and Dr Gina Kavanagh 11:14 CPC09 Dermatofibrosarcoma protuberans in a patient with acquired immune

deficiency syndrome responding to imatinib mesylate K. Horner, D. Adams and M. Ioffreda

11:21 CPC10 Patient-reported impact of scars measure (PRISM): development and

validation of a new skin scar patient-reported outcome measure B.C. Brown, S.P. McKenna, M. Solomon, J. Wilburn, D.A. McGrouther and A. Bayat

11:28 CPC11 Pemphigus vulgaris, alopecia areata and a mediastinal mass: a case of thymoma-associated autoimmunity H. Fassihi, S. Robertson, S. Hoque, J. King, B. Bhogal, M.M. Black and R.W. Groves

TU

ESDA

y 7

Th

JULy

– DET

AILED

PR

OG

RA

MM

E

23

11:35 CPC12 Severe systemic contact dermatitis due to diethylthiourea

S.A. Rice, T. Joseph, C.S. Macfarlane and B. Pees 11:42 CPC13 Calciphylaxis and sodium thiosulphate: a case report demonstrating

recent shifts in understanding and treatment A. Martin and G. Dawn

11:49 CPC14 Bullous pemphigoid following third-degree burns and skin grafting:

another example of epitope spreading D. O’Kane, L. Todd and S. Hoey

11:56 CPC15 A clinicopathological study of cases of synchronous melanoma and

renal carcinoma R.N. Matin, C.A. Harwood, L. McAndrew, R. Cerio, and P. Szlosarek

12:03 CPC16 A review of seven U.K. pedigrees with CyLD mutations: clinical

implications for mutation carriers N. Rajan, D. Bourn, C. Roberts, J.A.A. Langtry and J. Burn

12:10 Joint BAD/BSD Clinicopathology Lecture

Dermatopathological complications of chronic renal failure Dr Karen Blessing (Glasgow)

12:50 – 14:00 Lunch & Exhibition Hall 5 13:10 – 13:55 Lunchtime focus sessions Various 13:10 – 13:55 LFS01 Cancer Peer Review: how was it for you? Carron 1 The skin cancer peer review process is now well under way and a number of Teams

have been reviewed. This session will give members the opportunity to hear real life experiences of teams who have been through the process and ask questions on how issues were addressed.

13:10 – 13:55 LFS02 Clinical Excellence Awards Process Boisdale 1

Dr Jane Sterling & Dr Colin Holden How do people get local and national awards through the Clinical Excellence Awards

process? How can you improve your chances of an award in the next round? In this session, you will learn how an application to the ACCEA is evaluated, how it is scored and how to present your achievements in the context of the application form. The presentations and discussion will be led by those involved in different aspects of the awards process and will be relevant to members from all parts of the UK.

13:10 – 13:55 LFS03 Laser Update Dochart

Dr Richard Barlow Nearly a quarter of a century has passed since the theory of “selective photothermolysis”

was postulated by Anderson and Parrish. This has since been applied to the treatment of cutaneous vascular malformations, to pigmentary disorders, tattoos and unwanted hair.

Lasers have also become more sophisticated in terms cooling technology and the availability of higher fluences, bigger spot sizes and variable pulse durations.

Skin resurfacing, usually but not exclusively of wrinkles and acne scarring, has evolved from an early emphasis on ablation alone to recognition of the advantages of underlying thermal damage and eventually to attempts at non-ablative (including “fractional”) wounding of the dermis.

1 Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 1983; 220-524-7.

24

TU

ESD

Ay

7T

h J

ULy

– D

ETA

ILED

PR

OG

RA

MM

E 13:10 – 13:55 LFS04 Psychodermatology Alsh 2

Dr Anthony Bewley 14:00 – 17:00 BRITISh SOCIETy FOR DERMATOPAThOLOGy (PAGE 28 – 29)

LOMOND

14:15 – 17:00 BRITISh SOCIETy FOR DERMATOLOGICAL SURGERy (PAGE 30 – 32)

FORTh

14:00 – 15:15 SCIENTIFIC SESSION - SUBMITTED PAPERS Clyde Chairs: Dr Clive Archer and Dr Sean Whittaker 14:00 O-01 Survival outcomes and prognostic factors in mycosis fungoides/Sézary

syndrome: a comparison of the AJCC staging system with the revised ISCL/EORTC proposal N. Agar, E. Wedgeworth, J. Scarisbrick, S. Morris, M. Cox, A. Robson, E. Calonje,

C. Stefanato, T. Mitchell, S. Ferreira, K. Webb and S.J. Whittaker 14:15 O-02 Acute morbidity following a diagnosis of bullous pemphigoid

S. Langan, R. Hubbard, K. Fleming, C. Smith and J. West 14:30 O-03 Malignant potential and immunophenotypic expression of Ki67, p16,

p53 and hPv in vulval squamous cell carcinoma, vulval intraepithelial neoplasia and inflammatory dermatoses F. Salimullah, A. Faruqi and R. Cerio

14:50 Official Opening & welcome

Dr Clive Archer 15:00 – 15:30 GL01 Guest Lecture – Introduced by Dr Clive Archer Clyde vZv and the skin, a marriage of convenience Prof. Judy Breuer (London) Varicella zoster virus is the cause of chickenpox and zoster. In both diseases,

infection of the skin is central to the pathogenesis and life cycle of the virus. Spread of infection is by aerosolised cell free virus which is only present in vesicles on the skin and this form of the virus is also necessary for infection of nerve endings and latent persistence. The live attenuated vaccine, vOka strain is known to prevent viral replication in the skin while still inducing adequate immunity. The talk will focus on work to understand how VZV replicates in skin.

15:30 – 16:00 Tea and Exhibition Hall 5 16:00 O-04 An observational cohort study shows a high rate of familial

lichen sclerosus and associated vulval cancer suggesting a genetic contribution

V. Sherman, T. McPherson, M. Baldo, A. Salim, G. Xing-Hua and F.T. Wojnarowska

16:15 O-05 A prospective controlled trial of the effects of isotretinoin on quality of life and depressive symptoms

E. McGrath, F.B. Gillison, S. Protopapa, S.M. Skevington, A. Darvay and C.R. Lovell

TU

ESDA

y 7

Th

JULy

– DET

AILED

PR

OG

RA

MM

E

25

16:30 GL02 Guest Lecture – Introduced by Dr Clive Archer Clyde Gender and Autoimmune Diseases Professor Filippa Nyberg (Stockholm)

Autoimmune diseases affect about 8% of the population, predominantly women. Especially in Th2-dominated diseases such as systemic lupus erythematosus (SLE) and scleroderma, more than 90% of patients are women. The reason for the high prevalence in women is unclear. Women are known to respond to infection, vaccination and trauma with increased antibody production and a more Th2-predominant immune response, whereas a Th1 response and inflammation are usually more severe in men. A basic understanding of the pathophysiology behind sex differences in autoimmune diseases and an awareness of gender is necessary for dermatologists investigating and treating diseases such as lupus.

17:30 – 18:30 LEO PhARMA SATELLITE SyMPOSIUM (PAGE 55) DOChART

18:45 - 20:30 Presidents’ Reception Glasgow Science Centre 19:30 – 23:00 BSDS Annual Dinner House for an Art Lover

26

TU

ESD

Ay

7T

h J

ULy

– B

CD

S P

RO

GR

AM

ME

TUESDAy JULy 7Th BRITISh CONTACT DERMATITIS SOCIETy TIME PROGRAMME vENUE 09:30 – 13:00 BRITISh CONTACT DERMATITIS SOCIETy FORTh

Chairs: Dr Jane Sansom and Dr David Orton 09:30 Prosser - White Oration Perfumes: sensations and sensitizations Dr Olivia Bordalo (Lisbon, Portugal) 10:15 CD01 - Trends in contact allergy to fragrance chemicals in a U.K. patch

test centre C. Patterson and D. Orton 10:25 CD02 - Report of five patients allergic to fragrance hidden in products

claimed to contain no perfume I. Foulds 10:32 CD03 - Fragrance, thiuram and formaldehyde allergy is increasing in

healthcare workers: results from 2222 subjects patch tested over 25 years A. Pink, J.M.L. White and I.R. White

10:42 CD04 - Fragmentation of fragrance allergy: update 2007–2008 S. Goolamali, J.M.L. White, J. McFadden and I.R. White 10:49 CD05 - Patch testing in Ethiopia: a pilot study K.D. Bilcha, A. Aleye, D. Shibeshi and C. Lovell 10:59 CD06 - Allergy to silver in a patient with oral lichenoid reaction, with a

review of patch testing experience in 27 cases of oral lichenoid reaction M.J. Mohungoo and D.J. Gawkrodger 11:06 COFFEE hall 5

Chairs: Dr Mabs Chowdhury and Dr Barry Statham 11:25 CD07 - Patch testing in oral disease A. Kedward, J. Crawley, J. Marley, G. Cowan, P.-J. Lamey and K. Armstrong 11:35 CD08 - Allergic contact dermatitis to isopropyl lanolate present in a lipstick B. Arun, M.H. Beck and J.D.L. Williams 11:42 CD09 - Patch testing should be undertaken in hairdressers with dermatitis

regardless of atopy status R.L. O’Connell, J.M.L. White, I.R. White and J. McFadden 11:52 CD10 - The changing nature of occupational hand dermatoses in healthcare

workers: a comparison of patch testing and skin prick testing results in 1999 and 2007

L. Paul and M. Wilkinson 12:02 CD11 - Patch testing in patients treated with systemic immunosuppressive

agents and cytokine inhibitors J. Wee, J.M.L. White and I.R. White 12:09 CD12 - Defining the role of patch testing in the investigation of

drug reactions M. Shah and D.J. Gawkrodger 12:16 CD13 - Class effect of oral coumarins in the treatment of a patient with

TU

ESDA

y 7

Th

JULy

– BC

DS P

RO

GR

AM

ME

27

chronic idiopathic urticaria, angio-oedema and delayed pressure urticaria A.M. Marsland, V. Samarasinghe and C.E. Griffiths 12:23 CD14 - SPX sensitivity and Silhouette spectacles M.I. Darling, H.M. Horn and R.D. Aldridge 12:30 CD15 - Allergic contact dermatitis to dalbergiones present in a

cocobolo bracelet B. Arun, G. Street, B.M. Hausen, M.H. Beck and J.D.L. Williams 12:37 CD16 - Changing positivity: multicentre study of recent trends in patch

test allergen reactions from the British Contact Dermatitis Society standard series

E. Smith, O. Bodger and B. Statham 12:43 CD17 - Contact and photocontact sensitization in chronic actinic dermatitis A.L. Chew, S. Bashir, J. Hawk, R. Palmer, I.R. White and J. McFadden 12:53 CD18 - Occupational contact urticaria to pelargonyl vanillylamide used in

an incapacitant spray S. Gupta and G.A. Johnston

POSTERS CD19 - 2-monomethylol phenol: an unusual cause of allergic contact

dermatitis to footwear and sporting equipment I. Ali, J. Reed and S. Cooper CD20 - Food allergy with cutaneous manifestations in adults with eczema T. Patel and D.J. Gawkrodger CD21 - what are the possible allergens in chapatti flour? Report of a case

with contact urticaria and protein contact dermatitis A.V.Rajasekaran, M.R. Kaur and S.S. Velangi CD22 - Allergic contact dermatitis due to backing plastics in a transdermal

contraceptive patch S. Gupta, V. McNamara, E. Oloto and G.A. Johnston CD23 - A review of excipient ingredients in topical corticosteroid

preparations available in the U.K. C. Patterson, D. Orton and G. Ben-Zvi CD24 - Peristomal allergic contact dermatitis to stoma adhesive paste

containing Gantrez 425 (butyl ester of polymethylvinylether copolymer) but not to Gantrez 335 (isopropyl ester of polymethylvinylether copolymer) S. Field, C. O’Sullivan, M. Murphy and J. Bourke

28

TU

ESD

Ay

7T

h J

ULy

– B

SD P

RO

GR

AM

ME

TUESDAy 7Th JULy – BRITISh SOCIETy FOR DERMATOPAThOLOGy TIME PROGRAMME vENUE

08:15 – 09:15 BSD Executive Committee Meeting Ness

09:30 – 12:45 Clinicopathological Cases, Joint meeting with the British Clyde Association of Dermatologists (page 22 – 23)

12:10 – 12:50 Joint BAD/BSD Clinicopathology Lecture Clyde Dermatopathological complications of chronic renal failure Dr Karen Blessing (Glasgow)

13:30 – 13:55 BSD Annual General Meeting Lomond

14:00 – 17:00 BSD MAIN PROGRAMME LOMOND

Chairs: Dr Maureen Walsh and Dr Saleem Taibjee

14:00 Introduction and comment on posters

14:07 DP01 – Merkel cell polyomavirus detection in skin cancers from an immunosuppressed patient R.N. Matin, A. Gulati, P. Kader, J.M. McGregor, C.M. Proby, R. Cerio and C.A. Harwood

14:14 DP02 – Localization of varicella-zoster virus reactivation in neuronal and adnexal structures in skin M. Singh, R. Heseltine, J. Millar, R. Cerio, J. Breuer and E.A. O’Toole

14:21 DP03 – Indolent CD8-positive lymphoid proliferation of the ear R. Suchak, S. O’Connor and A. Robson

14:28 DP04 – Splenic B-cell marginal zone lymphoma presenting in the skin R.N. Matin, S.G. Agrawal, M. Jenner, R. Cerio, H. Rizvi and C.A. Harwood

14:35 DP05 – Primary cutaneous lymphoproliferative disorder showing biclonal and bilineage features A. Hafejee, L. Jamieson, J.E. Ferguson and E.J. Parry

14:42 DP06 – A case of primary cutaneous senile Epstein–Barr virus-related diffuse large B-cell lymphoma B. Martin, S.J. Whittaker and A. Robson

14:49 DP07 – Lymph node involvement in mycosis fungoides/Sézary syndrome: does positron emission/computed tomography imaging correlate with histology, immunohistochemistry and gene analysis?

E. Wedgeworth, T. Szyszko, M. O’Doherty, B. Wilkins, S.J. Whittaker and J. Scarisbrick

14:56 DP08 – Telangiectasia macularis eruptiva perstans associated with bone marrow mast cell KIT D816v mutation: a prognostic challenge M. Griffiths, R. Muc, P. Colloby, D. Milligan and A.H.M. Heagerty

15:03 DP09 – Spider telangiectasia macularis eruptiva perstans: a new entity? V. Elangasinghe, R. Graham-Brown and A. Fletcher 15:10 DP10 – Multiple epidermotropic metastatic melanomas: clinicopathological and dermoscopic correlation A.B. Alexandroff, J. Burns, A. Khan, J. Morlese, A. Fletcher, M. Bamford, S. Nicholson and D.J. McKenna

TU

ESDA

y 7

Th

JULy

– BSD

PR

OG

RA

MM

E

29

15:17 DP11 – Agminate Spitz naevi on the finger of a 10-year-old child: a rare presentation causing diagnostic confusion with malignant melanoma R. Suchak and E.J. Calonje

15:30 Coffee Hall 5

16:00 DP12 – Basal cell carcinoma in association with trichoblastoma/trichoepithelioma L. Melly and R.A. Carr

16:07 DP13 – A case of massive fat necrosis and overlying ulceration: a poorly understood and under-reported condition H. Malhomme de la Roche, H. Newton and P. Divekar

16:14 DP14 – Cutaneous neuroblastoma-like schwannoma: a report of two cases, one with a plexiform pattern R. Suchak, C. Bacchi, B. Maguire and E.J. Calonje

16:21 DP15 – Rupioid skin lesions: a returning phenomenon? V. Elangasinghe, G.A. Johnston and M. Bamford

16:28 DP16 – Genital and extragenital lichen sclerosis associated with generalized morphoea S. Dhoat, C.H. Orteu, F. Deroide and L. Melly

16:35 DP17 – Atypical sarcoidal necrobiosis lipoidica of the face and chest E. Kulakov, A. Abdullah, M. Maheshwari and M. Thomson

16:42 DP18 – Atypical necrobiosis lipoidica of the head and neck M. Lynch, G. Callagy and L.A. Murphy

16:49 DP19 – Basaloid squamous cell carcinoma with monster cells mimicking ‘pleomorphic’ nodular basal cell carcinoma C. Defty, J. Segen, J.J. Carter, I. Ahmed and R.A. Carr

16:56 Best presentation prize and close

Posters DP20 – Nonbullous variant of pemphigoid in a patient with absent C4 allotype: a lesson in immunology for dermatologists P.D. Yesudian, D. Shah, M. Giles and D. Williamson

DP21 – Eosinophilic variant of necrolytic migratory erythema L. Macfarlane, K. Robertson, S. Edwards, A. Affleck and C.J. Fleming

DP22 – Colonization of basal cell carcinoma and actinic keratosis by malignant melanoma in situ in a patient with xeroderma pigmentosum L. Smith and E. Husain

DP23 – Acquired reactive perforating collagenosis treated with low-dose isotretinoin R. Patalay, A. Kai, G. Stamp, F. Teixeira and A. Chu

DP24 – Syringoacanthoma: a rare mimic of seborrhoeic keratosis P.D. Yesudian, C. Platt and N. Kirkham

DP25 - An association between lichen planus and autoimmune blistering diseases A. Shipman, F.T. Wojnarowska and S. Cooper

DP26 - Subcutaneous nodules of the penis in an adolescent A. Fogo and P. Farrant

DP27 - Is quinine the culprit or a lentigo more likely? V. Scott-Lang and G. Dawn

30

TU

ESD

Ay

7T

h J

ULy

– B

SDS

PR

OG

RA

MM

ETUESDAy 7Th JULy – BRITISh SOCIETy FOR DERMATOLOGICAL SURGERy TIME PROGRAMME vENUE

14:00 – 17:00 BRITISh SOCIETy FOR DERMATOLOGICAL SURGERy FORTh

14:00 – 15:20 Session 1 Chair: Dr Graeme Stables 14:00 DS01 - Desmoplastic squamous cell carcinoma: an underemphasized,

locally aggressive variant P. Salmon, W. Hussein and N. Mortimer 14:10 DS02 - Increasing incidence of basal cell carcinoma in the under 30s

in the U.K. A.-M. Skellett, K.A. Wright, D.C. Greenberg and N.J. Levell 14:20 DS03 - The role of conventional naked eye examination, dermoscopy and

digital dermoscopy follow-up in the management of melanocytic skin lesions: a prospective study

S. Rajpara, P. Woo, F. Muller, S. Laube, N. Scott and A.D. Ormerod 14:30 DS04 - Consensus guidance on histological margins in variants of cutaneous

squamous cell carcinoma D.A.R. de Berker and J. Milne 14:40 DS05 - Audit of frozen-section histopathological margins in a newly

established Mohs micrographic surgery unit C. Cunningham, E. Jones, M. McMenamin and P. Ormond 14:50 DS06 - Management of basal cell carcinoma around the external

jugular vein A. Birnie, C. Thomas and R.J. Motley

14:56 DS07 - Secondary intention healing for surgical wounds on the dorsum of the hands

S. Lateo and J.A.A. Langtry 15:02 DS08 - Turner’s knot: the modified subcutaneous buried vertical mattress

suture. A new technique for closing high-tension surgical wounds? D. Coates and R.J. Turner 15:08 DS09 - Subungual pyogenic granuloma: recognition and management D.A.R. de Berker, B.M. Piraccini and B. Richert 15:14 DS10 - Lymphatic leak and lymphocoele development after simple

cutaneous surgery H. Al-Rawi and C.M. Lawrence 15:20 – 15:40 Coffee Hall 5 15:40 – 16:22 SESSION 2 - JOINT BSDS AND BCDG

Chairs: Dr Tamara Griffiths and Dr Rob Sheehan-Dare 15:40 DS11 – Phosphate-buffered saline as an effective alternate to melanocyte

media in autologous noncultured melanocyte transplantation A.P. Holla, K. Sahni, D. Parsad and A.J. Kanwar

TU

ESDA

y 7

Th

JULy

– BSD

S PR

OG

RA

MM

E

31

15:50 DS12 - Carbon dioxide laser treatment of rhinophyma: a review of 124 patients V. Madan, J. Ferguson and P.J. August 16:00 DS13 - Treatment of inflammatory acne with a 1450-nm smoothbeam diode

laser: a split-face randomized single-blinded controlled trial S. Darne, E. Hiscutt and D.C. Seukeran 16:10 DS14 - Side-effects of aesthetic dermal fillers for dermatologists J. Felton, S.M. Halpern and R. Emerson 16:16 DS15 - Treatment of scalp hyperhidrosis with intradermal botulinum toxin A

results in a marked improvement of quality of life A. Birnie and R.J. Motley 16:22 – 17:00 Session 3 Chair: Dr Rob Sheehan-Dare 16:22 DS16 - A case report of malignant melanoma in a user of Melanotan I R. Ellis, N. Kirkham and D.C. Seukeran 16:28 DS17 - The paired advancement flap/modified primary closure for nasal tip and

supratip defects: 50 cases of the successful use of another Zitelli pearl V. Madan and N.R. Telfer 16:34 DS18 - Paramedian forehead flap: an axial pattern flap based on the

supratrochlear artery vascular pedicle or is it random pattern flap? A study of 26 patients

R. Barry, A. Husain, C. Lawrence and J.A.A. Langtry 16:40 DS19 - Nasal sidewall rotation flaps N. Mortimer, E. Tan and P. Salmon 16:46 DS20 - Microcystic adnexal carcinoma of the forehead with extensive

supratrochlear perineural and intraneural infiltration extending into the orbit R. Barry, A. Husain, J. Dickinson and J.A.A. Langtry 16:52 DS21 - Aggressive growth pattern basal cell carcinoma and long-term

methotrexate therapy J. Shelley and C. Lawrence 17:00 – 17:30 BSDS AGM Forth Posters DS22 - The impact of Improved Outcome Guidance (IOG) for skin cancer:

a comparative re-audit of excision rates of basal cell carcinomas by general practitioners in South warwickshire

S. Khalid, A. Spicer, B. Gee and R. Carr DS23 - A significantly improved outcome for surgical excision of basal cell

carcinoma as a result of the audit process I. Ali, K. Sriprakash, B. Eve, K. Hollowood, J. Reed and R. Turner DS24 - Should all melanoma wider excision specimens undergo histological

examination? A pilot audit S. Law Pak Chong, V. Sharma, J. Garioch and M. Moncrieff DS25 - The role of a transplant–dermatology surveillance clinic in the

management of renal transplant recipients V. Samarasinghe, V. Madan, J. Varghese, S. Russell and J.T. Lear DS26 - Abstract withdrawn

32

TU

ESD

Ay

7T

h J

ULy

– B

SDS

PR

OG

RA

MM

E DS27 - The successful use of an advanced 650 nm intense pulsed light

(IPL ADv 650) – filtered broadband white light source – for the removal of red facial hair

K. Baxter, S. Hills and A. Layton DS28 - Nurse-led skin lesion clinics: impact on health literacy and

service provision K.A. Ward DS29 - Analysis of new patients attending a combined dermatological surgery

and oculoplastic surgery clinic R. Rahim and J.A.A. Langtry DS30 - what does a new Mohs’ surgery service see? An audit S. Garg and V. Ghura DS31 - Persistent eccrine porocarcinoma treated by Mohs’

micrographic surgery C. Gleeson, S. Goolamali, A. Robson, L. Ion and R. Mallipeddi DS32 - Electrosurgical treatment of gnathophyma A. Birnie, A. Belgi and R. Motley DS33 - Successful CO2 laser treatment of naevus lipomatosus

cutaneous superficialis S. Fatah, R. Ellis, D. Seukeran and A. Carmichael DS34 - Two-week wait skin cancer referrals: referral patterns, cancer incidence

and the media A. Lonsdale-Eccles, J. Croker, C. Slade, S. Traer, J. Hayes, R. Humphries, G. Rainger,

D. McCormick and S. Keohane

wED

NESD

Ay

8T

h JU

Ly – O

vER

vIEw

33

wEDNESDAy 8Th JULy – OvERvIEw

We

dn

esd

ay 8

th J

uly

Wednesday

8th

July

08:0

008:1

5

08:3

0

08:4

5

09:0

009.1

5

09:3

0

09:4

5

10:0

010:1

5

10:3

0

10:4

5

11:0

011:1

5

11:3

0

11:4

5

12:0

012:1

5

12:3

0

12:4

5

13:0

013:1

5

13:3

0

13:4

5

14:0

014:1

5

14:3

0

14:4

5

15:0

015:1

5

15:3

0

15:4

5

16:0

016:1

5

16:3

0

16:4

5

17:0

017:1

5

17:3

0

17:4

5

18:0

018:1

5

18:3

0

18:4

5

19:0

019:1

5

19:3

0

19:4

5

Cly

de

Au

dit

ori

um

Cly

de F

oyer

Are

a

Hall 5

Fo

rth

Lo

mo

nd

A

ud

ito

riu

m

Carr

on

1

Carr

on

2

Do

ch

art

1

Do

ch

art

2

Eti

ve

Fyn

e

Leven

Mo

rar

Ness

Katr

ine

Gala

1

Gala

2

KE

Y

Medic

al D

erm

ato

logy a

nd S

ubm

itte

d

papers

Dele

gate

In

form

ation

Wels

h C

ouncil

Speaker

Pre

vie

w

BS

PD

Com

mitte

e

UK

Pro

f G

roup

BJD

Meeting

Senio

r S

kin

Gro

up

Exhib

itio

n /

Poste

rs

BS

PD

Tra

inin

g

com

mitte

e -

BA

D

Com

mitte

eF

ocus

Sessio

n

Schering P

lough

Sate

llite

Sym

posiu

m

Janssen C

ilag S

ate

llite

S

ym

posiu

m

BA

D O

ffic

e

Sate

llite

S

ym

posia

BA

D

Sessio

ns

Additio

nal

Gro

ups

Non-B

AD

M

eetings

British S

ocie

ty for

Paedia

tric

Derm

ato

logy

08:0

0 -

09:0

09:0

0 -

10.0

0

Sessio

n J

udges

Com

mitte

e

Abbott S

ate

llite

S

ym

posiu

m

BA

D O

ffic

ers

Health Info

matics S

ub-c

om

mitte

e m

eeting

Wyeth

Hospitalit

y S

uite

Medic

al D

erm

ato

logy

Exhib

itio

n

19:0

0 -

- 20:0

016:0

0 -

17:0

017:0

0 -

18:0

018:0

0 -

19:0

0

Specia

l In

tere

st

Gro

ups

14:0

0 -

15:0

015:0

0 -

16:0

0

Lunch B

AD

Regis

tration O

pen

12:0

0 -

13:0

0

Stiefe

l S

ate

llite

S

ym

posiu

m

Exhbitio

nP

oste

r V

iew

ing

Exhib

itio

n

10.0

0 -

11:0

011:0

0 -

12:0

0

Annual G

enera

l M

eeting

Subm

itte

d

papers

Guest

Lectu

re

13:0

0 -

14:0

0

34

wED

NES

DA

y 8

Th

JU

Ly –

DET

AIL

ED P

RO

GR

AM

ME

wEDNESDAy JULy 8Th - DETAILED PROGRAMME TIME CODE PROGRAMME vENUE08:00 – 18:00 Registration desk open Clyde Foyer 08:30 – 10:30 Annual General Meeting (members only) Clyde 10:30 – 11:30 Coffee & Poster Viewing Hall 5 11:30 – 12:15 Scientific Session – Submitted Papers Clyde Chairs: Prof Colin Munro and Dr Stephen Jones 11:30 O-06 Responding to the commissioners: development of an integrated,

high-quality, consultant-led community dermatology service R. Healy, K. Thornton, C.H. Orteu, M.H.A. Rustin, J. Jones, T. Leslie, V. Hill, W.S. Robles, S. McBride and E. Seaton 11:45 O-07 Specialist provision of dermatology clinical assessment and treatment

services (CATS): 12 months’ data J.K. Schofield, L. Ogden, K. West, A. Yeates, M. Blanshard and N. Evans 12:00 O-08 Initial data from the U.K. epidermolysis bullosa database C. Moss, A. Todhunter, A. Wong, A.H.M. Heagerty, A. Martinez, R. Ramesh

and J. Mellerio 12:15 GL03 Guest Lecture – Introduced by Dr Clive Archer The future of Biological Therapies in Rheumatology Prof. Paul Emery (Leeds) Rheumatoid arthritis until relatively recently was considered a largely untreatable

disease. With the development of new therapies and the more aggressive use of traditional therapies has become is clear that there is a large reversible element. Therapy was initially restricted to those who had untreatable disease for two reasons, first these patients were considered the most in need and second there were doubts about long-term safety of these agents.

With increasing experience of these agents there has been confidence in using them earlier. As a result there has been a more aggressive remission induction approach which has been shown to be more likely to produce a biologic-free remission, and for some it is possible to stop all therapy once remission is reached. The availability of new agents which block costimulation and deplete B-cells has provided a further alternative and the licence of IL-6 blocking agents has further advanced therapeutic possibilities.

12:45 – 14:15 Lunch & Exhibition Hall 5 13:00 – 14:00 ABBOTT SATELLITE SyMPOSIUM (PAGE 56) CARRON

13:00 – 14:00 STIEFEL SATELLITE SyMPOSIUM (PAGE 56) LOMOND

13:00 – 14:00 JANSSEN CILAG SATELLITE SyMPOSIUM (PAGE 55) FORTh

14:15 – 17:45 BRITISh SOCIETy FOR PAEDIATRIC DERMATOLOGy LOMOND

wED

NESD

Ay

8T

h JU

Ly – D

ETA

ILED P

RO

GR

AM

ME

35

14:00 – 15:15 Scientific Session – Medical Dermatology & Submitted Papers Clyde Chairs: Dr Catherine Smith & Dr Claire Fuller 14:00 Introduction & Session Overview – Dr Clive Archer 14:05 MD01 Oral Ulceration Dr Ruth Murphy (Nottingham)

14:25 O-09 Management of pyoderma gangrenosum by U.K. dermatologists: a pilot study to inform a trial

F. Craig, K. Thomas, C. Layfield, J. Ingram, S. Muller, M.A. Ismail, R. Murphy, H. Qeyam, N.J. Levell, A.-M. Skellet, J. Batchelor, N. Cooke, G. Gupta, G. Wylie, G. Johnston, R. Gait, C. Lyon, D. Koch, H. Williams and A.D. Ormerod

14:40 O-10 Twenty cases of DRESS syndrome: culprits, clinical features, treatment

and outcome L.E. Proudfoot, K. Watson, E.M. Higgins and D.J. Creamer 14:55 O-11 Assessment of cardiovascular status in patients with moderate to

severe psoriasis: a prospective case–controlled cohort study C.L. Martyn-Simmon, R.R. Ranawaka, M.A. Crook, M.S. Marber, P.J. Chowienczyk,

C.H. Smith and J.N.W.N. Barker 15:10 – 15:50 Tea & Exhibition Hall 5 15:50 – 17:50 Scientific Session – Medical Dermatology & Submitted Clyde Papers Continued… Chairs: Dr Jane McGregor and Dr Claire Fuller 15:50 O-12 X-linked dominant protoporphyria: a new form of porphyria caused by

a gain of function mutation in aminolaevulinic acid synthase S.A. Holme, S.D. Whatley, M.N. Badminton, G.H. Elder, J.T. Marsden, Y. Ma, G.M.

Vergani and A.V. Anstey 16:05 MD03 The risks and benefits of exposure to sunlight Prof. Andrew Ness (Bristol) 16:35 O-13 Predicting risk of nonmelanoma skin cancer in renal

transplant recipients S. Milborrow, J. Dalley, J. Lear, S. Russel, V. Samarasinghe and T. Fryer 16:50 O-14 An analysis of the spectrum of skin tumours in the west of Scotland

renal transplant population L.J. Mackintosh, A. Makrygeorgou, C.C. Geddes and R.M. Herd 17:05 MD04 hIv and the skin Dr Ray Fox (Glasgow) 17:35 O-15 An investigation of the role of alcohol biomarkers in the detection of

excessive alcohol consumption in patients with psoriasis M.A. McAleer, S. Cunningham, P. Collins, S.C.F. Rogers and B. Kirby 18:00 – 19:00 SChERING PLOUGh SATELLITE SyMPOSIUM (PAGE 57) FORTh

17:30 Sports competitions & BSF Walk (page 14) Various

36

wED

NES

DA

y 8

Th

JU

Ly –

BSP

D P

RO

GR

AM

ME

wEDNESDAy 8Th JULy BRITISh SOCIETy FOR PAEDIATRIC DERMATOLOGy– COMBINED wITh ThE FRENCh PEADIATRIC SOCIETy MEETING

TIME PROGRAMME vENUE

14:10 – 17:30 BRITISh SOCIETy FOR PAEDIATRIC DERMATOLOGy Lomond

Chair: Dr Nigel Burrows

14:10 PA01 – Randomized controlled trial fails to show superiority of wet wraps over conventional therapy in the treatment of mild to moderate atopic eczema in children under 5 years

A. Bryden, S. Ogilvie, R.S. Dawe and S. Lewis-Jones

14:20 PA02 – Breakdown of the skin barrier induced by aqueous cream: implications for the management of atopic eczema

T. Al Enezi, A. Sultan, J. Chittock, M. Moustafa, S. Danby and M.J. Cork

14:30 PA03 – Children’s preference in selecting an emollient of their choice A. Aslam

14:40 PA04 – Patient-oriented SCORAD (PO-SCORAD): a self-assessment score in atopic dermatitis: a preliminary feasibility study

M. Vourch-Jourdain, S. Barbarot, A. Taieb, T. Diepgen, M. Ambonati, V. Durosier, V. Sibaud and J.F. Stalder

14:50 PA05 – An audit to evaluate service outcome in children with atopic eczema attending a paediatric dermatology clinic

C. Devereux, J. McKenna, E.A. Bingham and S. Hoey

15:00 ‘Skin Diseases and the Ocular Surface’ Mr Ken Nischal (London)

15:40 Tea Hall 5

Chair: Dr Pamela McHenry

16:00 PA06 – Medial frontofacial capillary malformations: a descriptive study L. Sillard, C. Labreze, J. Mazereeuw-Hautier, S. Barbarot, V. Viseux, D. Bessis, P. Vabres, G. Lorette, F. Berthier and J.-P. Lacour

16:10 PA07 – Propranolol for severe infantile haemangiomas V. Sans, E. Dumas-De-La-Roque, F. Boralevi, M. Cario-André, D. Lipsker,

J. Mazereeuw-Hautier, A. Taïeb and C. Léauté-Labrèze

16:20 PA08 - A genotypic and phenotypic study of 112 cases of junctional epidermolysis bullosa

C. Chiaverini, A. Charlesworth, V. Bronsard, C. Bodemer, G. Meneguzzi and J.-P. Lacour

16:30 PA09 - herlitz junctional epidermolysis bullosa: a retrospective epidemiological study of 28 patients

R. Ramesh, R. Ward, N. Kingsbury, D. James, E. McAndrew and C. Moss

16:40 PA10 - Loss-of-function mutations in the ANTXR2 (CMG2) gene underlie both juvenile hyaline fibromatosis and infantile systemic hyalinosis

K. Fong, G. El-Kamah, S. Clements, J. Lai-Cheong, J. Mellerio, M. El-Darouti and J. McGrath

16:50 PA11 - Cutaneous warts in a paediatric renal transplant population S.L. Chua, A. Lunn, J.C. Ravenscroft and A. Watson

wED

NESD

Ay

8T

h JU

Ly – B

SPD

PR

OG

RA

MM

E

37

17:00 PA12 - Sitosterolaemia: a very rare plant sterol disorder presenting in infancy with hepatic failure, haemolysis and cutaneous xanthoma

R.M.R. Hearn, R.A. Wilkie, D. Kastner, S. Height, A. Baker and S. Lewis-Jones

17:06 PA13 - Fabry’s disease in a female patient A. O’Loughlin and B. O’Donnell

17:12 PA14 - Self-mutilation as a presenting feature of inherited erythromelalgia and paroxysmal extreme pain disorder in a 17-month-old child

A.Woods, A. Clarke, F. Elmslie and R. Marsden

17:18 PA15 - Panton–valentine leucocidin-associated Staphylococcus aureus: a super bug we need to know

M. Kalavala, R. Frost and J. Hughes

17:24 PA16 - ‘Matchstick’ eyebrow hairs: dermoscopic clues to the diagnosis of Netherton syndrome

E. Goujon, F. Beer, S. Fraitag and P. Vabres

Close

Posters PA17 - Preschool nurseries: are they SunSmart? K. Shalders and I. Zaki

PA18 - LEOPARD syndrome with multiple granular cell tumours T. Gunson, N. Hashim and G. Sharpe

PA19 - holistic assessment of eczema: are we complying with NICE guidelines?

F. Gohar and C. Moss

PA20 - A cutaneous manifestation of a novel heterozygous alpha-1-antitrypsin F null allele deficiency in infancy

C. Borysiewicz, O.E. Dadzie, M. Pope, J. Sheldon and N. Morar

PA21 - Alopecia areata developing after tinea capitis: a Koebner phenomenon

A. Fogo, R. Morris-Jones and E.M. Higgins

PA22 - Management of a chronic vasculitic leg ulcer with systemic immunosuppressant therapy and autologous keratinocyte cell spray

M. Moustafa, J. Carr, C. Longton, J. Clarke, S. MacNeil and M. Cork

PA23 - Urgent paediatric referrals to dermatology: a 7-year study M. Shah

PA24 - Patch testing is a useful investigation in children with eczema M. Moustafa, C. Holden, P. Athavale, M. Cork, A. Messenger and D.J. Gawkrodger

PA25 - EMLA®-related histological changes caused by topical application J. Gass, E. Rytina, N.P. Burrows, J. Grant and P. Todd

PA26 - A new autosomal dominant pure hair–nail ectodermal dysplasia showing variable expression within a family

C. Vlachou, E.A. O’Toole, D.P. Kelsell and K. Batta

PA27 - ‘Leather sofa dermatitis’ due to contact allergy to chrome - an unusual cause of eczema in a child

A. Mahto and B. De Silva

PA28 - Sequestrated meningocoele within a naevus sebaceous of Jadassohn on the scalp of a child

F. Rees, S. Cheng, K. Kulkarni and S. Varma

38

NO

TES

Th

UR

SDA

y 9

Th

JULy

– Ov

ERv

IEw

39

ThURSDAy 9Th JULy – OvERvIEw

Th

urs

da

y 9

th J

uly

Thurs

day 9

th

July

07:3

007:4

5

08:0

008:1

5

08:3

0

08:4

5

09:0

009.1

5

09:3

0

09:4

5

10:0

010:1

5

10:3

0

10:4

5

11:0

011:1

5

11:3

0

11:4

5

12:0

012:1

5

12:3

0

12:4

5

13:0

013:1

5

13:3

0

13:4

5

14:0

014:1

5

14:3

0

14:4

5

15:0

015:1

5

15:3

0

15:4

5

16:0

016:1

5

16:3

0

16:4

5

17:0

017:1

5

17:3

0

17:4

5

18:0

018:1

5

18:3

0

18:4

5

Cly

de

Au

dit

ori

um

Cly

de F

oyer

Are

a

Hall 5

Fo

rth

Lo

mo

nd

Au

dit

ori

um

Als

h 1

Als

h 2

Bo

isd

ale

1

Bo

isd

ale

2

Carr

on

1

Carr

on

2

Do

ch

art

1

Do

ch

art

2

Eti

ve

Fyn

e

Leven

Mo

rar

Ness

Katr

ine

Gala

1

Gala

2

KE

Y

Aste

llas S

ate

llite

Sym

posiu

m

BA

D E

xecutive C

om

mitte

e

LF

S06

LF

S07

LF

S08

His

torical S

ym

posiu

m

British P

hoto

derm

ato

logy G

roup

His

torical C

om

mitte

e

BP

G A

GM

His

torical S

ym

posiu

m

Lunch

14:0

0 -

15:0

015:0

0 -

16:0

007:3

0 -

8:0

011:0

0 -

12:0

09:0

0 -

10.0

010.0

0 -

11:0

008:0

0 -

09:0

0

Lunch B

AD

Regis

tration O

pen

Exhib

itio

n

Join

t B

AD

/BD

NG

Sessio

nJoin

t B

AD

/BD

NG

Sessio

n

18:0

0 -

19:0

016:0

0 -

17:0

012:0

0 -

13:0

017:0

0 -

18:0

013:0

0 -

14:0

0

Additio

nal

Gro

ups

Non-B

AD

Meeting

Sate

llite

Sym

posia

BA

D S

essio

ns

Specia

l

Inte

rest

Gro

ups

Exhib

itio

n /

Poste

rs

BA

D

Com

mitte

e

LF

S05

Dele

gate

Info

rmation

Pro

fessors

& R

egis

trars

Foru

m

Exhib

itio

n

Guest Lectu

re R

ook

Ora

tion

Pro

f &

Regis

trars

Foru

m

CM

F B

reakfa

st

BP

G C

om

mitte

e

Speaker

Pre

vie

w

Focus

Sessio

n

BS

F G

rants

Advis

ory

CE

D E

ditorial B

oard

BA

D O

ffic

e

Exhib

itors

Meeting

UK

Derm

ato

logy C

linic

al T

rails

Netw

ork

AG

MIID

2013 P

lannin

g C

om

mitte

e

Acne G

enetics S

teering G

roup

UK

Derm

ato

logy C

linic

al T

rails

Netw

ork

Panel M

eeting

Sessio

n J

udges

40

Th

UR

SDA

y 9

Th

JU

Ly –

DET

AIL

ED P

RO

GR

AM

ME

ThURSDAy JULy 9Th – DETAILED PROGRAMME TIME CODE PROGRAMME vENUE08:00 – 18:00 Registration desk open Clyde Foyer 08:30 – 12:15 Professors & Registrars Forum Clyde 08:30 – 10:25 Chairs: Prof. Nick Reynolds and Prof. Alex Anstey 08:30 RF01 Polymorphic variants in PTGS2 and skin cancer risk W.L. Ho, R. Akhurst, M. Laing, G. Callaveri, P. O’Kelly, P. Conlon

and G.M. Murphy 08:45 RF02 Genetic polymorphism in MTHFR CLCN6 associated with skin cancer in

organ transplant and nontransplant patients M. Laing, W.L. Ho and G.M. Murphy 09:00 PR01 Update on the UK Dermatology Clinical Trials Network Prof. Hywel Williams (Nottingham) 09:20 RF03 The functional role of hLA-Cw6 in psoriasis R. Mak, C. Hundhausen, E. Botti, M. Marget and F. Nestle 09:35 PR02 Translating science to the clinic: the example of psoriasis Prof. Jonathan Barker (London) 09:55 RF04 A successful therapeutic model for psoriasis: recapitulation of human

psoriasis in a xenotransplantation mouse model G. Perera, D. Kassen and F. Nestle 10:10 RF05 Could transient elastography reduce the need for liver biopsy? A. Bray, I. Barnova, R. Przemioslo and C.T.C. Kennedy 10:25 – 11:10 Coffee & Exhibition Hall 5 11:10 – 12:15 Chairs: Dr Mark Goodfield and Dr Sally Ibbotson 11:10 RF06 A case–control study to investigate the clinicopathological predictors of

sentinel node biopsy positivity and outcome in melanoma patients A. Mitra, C. Walker, M. Cook, B. Powell, M. Kissin, G. Layer, J. Smallwood, C.

Ottensmeir, P. Stanley, H. Peach, F. Elliot, M. Iles, J. Barrett, D.T. Bishop and J. Newton-Bishop

11:25 PR03 Drugs/Chemicals that Interact with Light: The Clinical Consequences Prof. James Ferguson (Dundee) 11:45 RF07 Poikilodermatous mycosis fungoides: a study of the clinicopathological,

immunophenotypic and prognostic features R. Abbott, D. Sahni, A. Robson and J. Scarisbrick 12:00 RF08 Reduced expression of basal keratinocyte stem cell markers and altered

integrin profiles in Kindler syndrome skin J.E. Lai-Cheong, A. Tanaka, M. Parsons and J.A. McGrath

Th

UR

SDA

y 9

Th

JULy

– DET

AILED

PR

OG

RA

MM

E

41

12:15 GL04 Arthur Rook Oration Guest Lecture – Introduced by Dr Clive Archer Immunology of Atopic Dermatitis Prof. Donald Leung (Denver, USA)

During recent years, there has been considerable progress in our understanding of mechanisms underlying atopic dermatitis (AD), a familial chronically relapsing skin disease that frequently has its onset during early infancy and childhood. This lecture will provide an overview of new insights into the immunology of AD and the lab bench to bedside lessons physicians and scientists can glean from this common skin disease. The major theme will highlight how the interactions between skin barrier dysfunction as well as abnormal innate and adaptive immune responses contribute to the pathobiology of AD.

13:00 – 14:00 Lunch & Exhibition Hall 5 13:00 – 14:00 hISTORICAL COLLECTION SyMPOSIUM BOISDALE

13:10 – 13:55 Lunchtime focus sessions Various 13:10 – 13:55 LFS05 Clinical Service Issues Alsh 2 Involving patients: harnessing the power of the Patient voice Panel Discussion Increasingly in health care we are advised that we must involve patients in

decision making, forming partnerships with patients can have mutual benefits. What is patient power and how can we channel it to support

dermatology services. Commissioning, service re-design or improvement – How can patients influence

the decision makers? This session will be open to BAD Members, BDNG members and Patient Support

Group representatives. 13:10 – 13:55 LFS06 Common and rare tropical diseases that shouldn’t Carron be missed Dr Rachael Morris-Jones

Approximately 10% of travellers are ill on their return home. Skin disease is one of the most common reasons why medical attention is sought. Cutaneous manifestations may represent localised tropical disease however an underlying systemic disorder should not be missed. A case-based approach to the geography, cutaneous signs, investigation and management of tropical dermatology.

13:10 – 13:55 LFS07 Surgical Pearls Dochart Dr Catriona Irvine & Dr Richard Motley Experienced dermatological surgeons Richard Motley and Catriona Irvine will

present a number of ‘Surgical Pearls’ - simple ideas, tricks and tips to take home and use in day to day dermatological surgery; anything from novel suture technique, helpful tips for painless local anaesthetic injection, useful items of equipment and much more...

13:10 – 13:55 LFS08 Neonatal dermatology you can’t afford to miss Forth Dr Cameron Kennedy & Dr Lindsay Shaw

The talk will focus on the differential diagnosis of physical signs such as papules, nodules, pustules, blisters and purpura, and easily recognisable conditions such as haemangioma, with an emphasis on diseases which can either be organ and life threatening (e.g. skin failure, systemic infection, malignancy) or a harbinger of serious disease later. Where appropriate, comparison will be made with common self-limiting neonatal skin disorders.

42

Th

UR

SDA

y 9

Th

JU

Ly –

DET

AIL

ED P

RO

GR

AM

ME

14:00 – 17:00 BRITISh PhOTODERMATOLOGy GROUP LOMOND

14:10 – 17:15 Joint Meeting British Association of Dermatologists and British Clyde Dermatological Nursing Group

Chairs: Dr Clive Archer and Ann Davies 14:10 JM01 The future of the nurse consultant role Karina Jackson 14:30 JM02 Biological therapies: a supporting framework Liz Parrish 14:50 JM03 The nurse specialist: balancing primary and secondary care Jill Peters

15:10 JM04 NICE guidelines for management of atopic eczema in children Dr Sue Lewis-Jones 15:40 – 16:15 Coffee & Exhibition Hall 5 16:15 – 17:15 Chairs: Dr Sue Lewis-Jones and Ann Davies 16:15 JM05 Ethnic Dermatology: clinical problems and pigmented skin Dr Clive Archer 16:45 JM06 Crossing the divide: surgery without the RCS Mr Ralph Graham 17:30 – 18:30 ASTELLAS SATELLITE SyMPOSIUM (PAGE 57) FORTh

19:30 – 00:00 Annual Dinner Kelvingrove

Th

UR

SDA

y 9

Th

JULy

– hIST

OR

ICA

L PR

OG

RA

MM

E

43

ThURSDAy JULy 9Th – hISTORICAL PROGRAMME TIME CODE PROGRAMME vENUE

13:00 - 14:00 hISTORICAL SyMPOSIUM BOISDALE 1

13:00 Lunch Boisdale 2

Chair: Dr Nick Levell 13:10 h01 Sushruta, a ‘Father of Dermatological Surgery’ V. Elangasinghe and D.J. McKenna 13:20 h02 Leviticus: the Dermatologists’ handbook in the Bible P.D. Yesudian and R.E.A. Williams 13:30 Smallpox: the triumph of science over nature Dr Sue Lewis-Jones (Dundee) – Guest Lecture POSTERS h03 Ian Bruce Sneddon: a retrospective M.J. Mohungoo and A.J. McDonagh h04 henry Renwick vickers (1911–1993): a retrospective J.M.R. Goulding and T.J. Ryan h05 The bee’s knees: a history of bee products in dermatology L.L. Griffin, S.M.C. George and C.C. Harland h06 The understanding of venous leg ulcers: a historical perspective C. Defty and J.E. Gach h07 was porphyria cutanea tarda (PCT) the correct diagnosis in Admiral Francis Beaufort? N.J. Levell and T.J. Peters h08 The history of the use of liquid nitrogen and the development of

cryotherapy as a medical application S. Gupta and D.J. McKenna h09 Shedding light on the history of phototherapy A.-M. Skellett and N.J. Levell h10 history of the Aleppo boil W.M. Bakkour and B.C. Gee h11 An historical stitch-up: the quest for an ideal suture material V. Elangasinghe, D.J. McKenna and N.J. Levell h12 Dermatology through history as described in literature A. Amin and A. Woollons h13 The history of dermatological moulage in Russia A.B. Alexandroff and E. Burova h14 Thorium X treatment in dermatology: a ticking time bomb J. Natkunarajah, K. Gordon and S. Cliff

44

Th

UR

SDA

y 9

Th

JU

Ly –

BP

G P

RO

GR

AM

ME

ThURSDAy 9Th JULy – BRITISh PhOTODERMATOLOGy GROUP

TIME PROGRAMME vENUE13:30 – 14:00 BRITISh PhOTODERMATOLOGy GROUP AGM Lomond

14:00 - 17:15 BRITISh PhOTODERMATOLOGy GROUP LOMOND

Chairs: Prof Antony Young, Dr David Taylor 14:00 Sun exposure patterns; lessons learnt using time-resolved personal

electronic Uv dosimetry Guest Lecture Dr Elisabeth Thieden (Copenhagen) 14:35 My Photodermatology patients - their diagnoses and how I manage them Guest Lecture Prof. John Hawk (London) 15:10 PD01 – Mild erythropoietic protoporphyria (EPP): a diagnostically difficult

version of EPP presenting atypically and sometimes without pain K. Bhargava and R. Sarkany 15:25 PD02 – Pursuit of a tan through internet-sourced injectable melanotropic

peptides: association with darkening of melanocytic naevi E.A. Langan, D. Ramlogan, L.A. Jamieson, J. Varghese and L.E. Rhodes

15:40 Tea & Coffee Break Hall 5

Chairs: Dr Neil Gibbs, Dr Robert Sarkany 16:15 PD03 – hereditary erythropoietic protoporphyria (EPP) presenting in

old age with an unexpected genotype: lessons for the pathogenesis of symptoms in EPP

H. Fassihi, M. Badminton, J. Hawk, S. Whatley and R. Sarkany 16:30 PD04 - A double-blind randomized controlled clinical trial comparing the

effects of narrowband ultraviolet (Uv) B (TL-01) or UvA on vitamin D levels, blood pressure, insulin sensitivity and ventricular volume

J. Wishart and R. Scragg 16:45 PD05 - The pathogenesis of porphyria cutanea tarda: uroporphyrin kills

cells by causing cytosolic damage J. Lim, S. Walker and R. Sarkany 17:00 PD06 - Nationwide audit of erythema grading and recording

during phototherapy P. Beattie and F. Macdonald 17:15 Close of meeting Posters PD07 - Narrowband ultraviolet B phototherapy does not influence serum

and red cell folate levels in patients with psoriasis R. Rose, R. Batchelor, D. Turner and V. Goulden

Th

UR

SDA

y 9

Th

JULy

– BP

G P

RO

GR

AM

ME

45

PD08 - Narrowband ultraviolet A-1: pigmentation and erythema in normal skin and hazard estimation

O. Al Ofi, C. Edwards and A.V. Anstey PD09 - Sun protection practices in Northern Ireland: results from the

NI Omnibus Survey September 2008 R. Boyle, A.H. O’Hagan, S. Gordon, G. McIlwee, P. Loan, A. Gavin and C. Mason PD10 - A randomized, double-blind, negatively controlled pilot study to

determine whether the use of emollients or calcipotriol could alter the sensitivity of the skin to ultraviolet (Uv) radiation during phototherapy with narrowband UvB

A.-M. Skellett, L. Swift, E. Tan and J. Garioch PD11 - Factors associated with severe pain during 5-aminolaevulinic

acid-photodynamic therapy for superficial basal cell carcinoma in Tayside: a review of 9 years’ data

A. Waters, R. Dawe and S. Ibbotson PD-12 - Narrowband (TL-01) ultraviolet B phototherapy: the introduction

of phototesting M.J. Mohungoo and S.E. Cockayne PD-13 - A regional audit on the use of minimal erythema dose and minimal

phototoxic dose testing in phototherapy D.S. Brass, A.S. Alkali, J.M. Ellison, T. Sinha and R.M. Azurdia PD-14 - Psoralen and ultraviolet A (PUvA) in the treatment of

granuloma annulare F. Browne, D. Turner and V. Goulden

46

FRID

Ay

10

Th

JU

Ly –

Ov

ERv

IEw

FRIDAy 9Th JULy – OvERvIEwF

rid

ay 1

0th

Ju

ly

Frid

ay 1

0th

Ju

ly

08

:00

08

:15

0

8:3

0

08

:45

0

9:0

00

9.1

5

09

:30

0

9:4

5

10

:00

10

:15

1

0:3

0

10

:45

11

:00

11

:15

11

:30

11

:45

1

2:0

01

2:1

5

12

:30

1

2:4

5

Cly

de

A

ud

ito

riu

m

Cly

de

Fo

ye

r A

rea

Ga

la 1

Ga

la 2

KE

YB

AD

S

essio

ns

Sp

ecia

l In

tere

st

Gro

up

s

Exh

ibitio

n /

P

oste

rsB

AD

C

om

mitte

e

CP

D c

on

t…

De

leg

ate

In

form

atio

nF

ocu

s

Se

ssio

nA

dd

itio

na

l G

rou

ps

No

n-B

AD

M

ee

tin

gS

ate

llite

S

ym

po

sia

BA

D O

ffic

e

Sp

ea

ke

r P

revie

w

Co

ffe

e

GL

5C

on

tin

uin

g P

rofe

ssio

na

l D

eve

lop

me

nt

12

:00

- 1

3:0

00

8:0

0 -

09

:00

9:0

0 -

10

.00

10

.00

- 1

1:0

011

:00

- 1

2:0

0

FRID

Ay

10

Th

JULy

– DET

AILED

PR

OG

RA

MM

E

47

FRIDAy 10Th JULy – DETAILED PROGRAMME TIME CODE PROGRAMME vENUE08:30 – 13:00 Registration desk open Clyde Foyer 09:00 – 10:30 Continuing Professional Development Clyde

09:00 – 10:30 Chairs: Dr David Eedy and Dr Jane Sansom 09:00 CPD01 e-learning Dr Robert Charles-Holmes 09:30 CPD02 Update & management of therapeutic advances in melanoma Dr Paul Nathan 10:00 CPD03 what’s new in paediatric dermatology Dr Jemima Mellerio 10:30 GL05 Guest Lecture – Introduced by Dr Clive Archer Medical Education, past present and future Professor Kenneth Calman (Glasgow, UK) The presentation will cover the growth and development of medical education

over the centuries and consider the changes which have occurred in methods, and assessment. It will look ahead to future developments in the context of the professionalism required to practice medicine in the 21st century.

11:00 Coffee Clyde Foyer 11:25 – 12:30 Continuing Professional Development Clyde

11:25 – 12:30 Chairs: Dr Clive Archer and Prof. Rod Hay 11:25 CPD04 what’s new in Surgical Dermatology Dr Richard Motley 12:00 CPD05 what’s new in Cosmetic Dermatology Dr Chris Zachary 12:30 President’s Address Dr Mark Goodfield 12:45 Meeting Close

ADDITIONAL MEETINGS MON 6Th JULy TIME MEETING ROOM

17:45 – 19:00 Changing Faces Reception Morar

Changing Faces invites you to a Reception to mark the launch of our Face Equality campaign in Health hosted by James Partridge OBE, founder and CEO, Changing Faces – find out how you can bring good psycho-social rehabilitation to your patients with disfiguring skin conditions To find out more, contact Henrietta Spalding: henriettas@changingfaces.org.uk

TUES 7Th JULy TIME MEETING ROOM

15:40 – 16:22 British Cosmetic Dermatology Group Forth

The BCDG Programme will be run jointly with the BSDS programme and incorporated into the main BSDS session running from 14:00 – 17:00. Please see pages 30 – 31 for details.

For further information please contact Tamaragriffiths@aol.com

17:30 – 18:30 Dermatology Teachers Leven

The Annual Dermatology Teachers Meeting is an opportunity to discuss issues in education. On the agenda is the new Expert Lecture Series that has recently been commissioned and there will also be an opportunity to provide an update and a forum for discussion for the e-learning for health project.

I do hope that you can come along. – Dr Jane McGregor

17:30 – 18:30 The vitiligo Support Group 25th Anniversary reception Morar

For further information please contact conference@bad.org.uk

wED 8Th JULy TIME MEETING ROOM

17:30 – 18:30 Senior Skin Group Dochart 1

For further information please contact maggie@kirkup.plus.com

ThURS 9Th JULy TIME MEETING ROOM

07:30 – 08:30 Christian Medical Fellowship Leven If you would like to reserve a place at the breakfast please contact: conference@bad.org.uk

48

AD

DIT

ION

AL

MEE

TIN

GS

BRISTOL CUP POSTERS The posters are situated within the exhibition area Hall 5 and there will be a dedicated poster viewing hour on wednesday July 8th from 10:30 – 11:30. All presenting authors have been asked to stand by their poster at this time.

Richard Stoughton Poster AwardRS01 Amyloidosis: Diagnosis and prognosis L. Dohse, T. Ferringer and O.F. Miller Blistering DisordersP01 Pemphigoid gestationis: early onset and blister formation are associated with adverse

pregnancy outcomes C-C. Chi, S-H. Wang, R. Charles-Holmes, C. Ambros-Rudolph, J.J. Powell, R.E. Jenkins, M. Black and F.T. Wojnarowska P02 Bone marrow transplantation for congenital erythropoietic porphyria: report of six cases R. Katugampola, M. Badminton, A.Y. Finlay, S. Whatley, J.-C. Deybach, H. Puy, C. Ged, H. de Verneuil and A.V. Anstey P03 Neurological disease as a predisposing factor to bullous pemphigoid: an epidemiological

and immunopathological study K. Taghipour, B. Bhogal, V.A. Venning, R.W. Groves and F.T. Wojnarowska P04 Treatment of pemphigus vulgaris with rituximab E. Craythorne, S. Warnakulasuriya, G. Mufti and A.W.P. du Vivier P05 Desmoglein 1 and 3 levels following rituximab treatment for pemphigus vulgaris C.L. Martyn-Simmons, M. Saha, B. Bhogal and R.W. Groves

Inflammatory Skin Diseases (including Acne, Eczema and Psoriasis)P06 weekly azathioprine pulse therapy for the treatment of psoriasis: an open-label

pilot study K.K. Verma and A. Malhotra P07 Psoriasis: crucial role of LXR- RNomics D.S. Gupta, D. Kaul, A.J. Kanwar and D. Parsad P08 Do patients on methotrexate understand the potential risks? A. Kedward and E.A. Bingham P09 The cutaneous microenvironment in papulopustular rosacea S. Ni Raghallaigh and F.C. Powell P10 Retrospective review of patch testing conducted in our department over a 5-year period

to determine the rate of allergic contact dermatitis among various occupations C. Cusack and P.A. Marren P11 Readability scores for patient information leaflets used in a contact dermatitis clinic R.F. Davis and G.A. Johnston P12 Treatment of scalp psoriasis with adalimumab: results of the BELIEvE study D. Thaçi, J.-P. Ortonne, M. Goodfield, P. Spuls, A. Katsambas, G. Stingl, J. Sanchez Carazo, M. Ali Gürer, P. Sproegel, H.-U. Esslinger, K. Unnebrink and H. Kupper P13 Etanercept in patients with moderate to severe plaque psoriasis: a retrospective case

cohort analysis G. Perera, A. Fonia, C. Smith and J.N.W.N. Barker

PO

STER

S

49

50

PO

STER

SP14 A retrospective study of 15 patients treated with infliximab: is weight gain an important

consideration? E. Kulakov, M. Kaur and S.S. Velangi P15 Comparison of hospitalization and serious infections rates among patients with

moderate to severe psoriasis treated with ustekinumab: comparisons with a large healthcare claims database

E. Healy, B. Schenkel, S. Li, N. Yeilding, C. Han, N. Wasel, N. Korman, M.H.A. Rustin, on behalf of the PHOENIX 1 and PHOENIX 2 investigators

P16 A study to examine if the hLA-Cw0602 allele is a predictor of response to tumour

necrosis factor-a inhibitors in the treatment of psoriasis C. Ryan, J. Kelleher, P. Collins, S.C.F. Rogers and B. Kirby P17 Inpatient care for psoriasis: a retrospective study of inpatient admission data and the

impact of new management modalities in psoriasis K. Jackson, R.W. Groves, C. Smith and J.N.W.N. Barker P18 Ustekinumab has a consistent efficacy and safety profile in patients with moderate to

severe psoriasis: results from the PhOENIX 1 and 2 clinical trial programme J.C. Prinz, G. Stingl, N. Yeilding, P. Szapary, S. Li, K. Reich, on behalf of the PHOENIX 1 and

PHOENIX 2 Investigators P19 Revisiting intense pulsed light use for acne M. Taylor and M. Gonzalez P20 Nurse-led preassessment may improve safety in patients commencing biologics

for psoriasis C. Roberts, C. Gradwell and R. Murphy P21 Skin protease inhibitors: a new treatment for atopic dermatitis S. Danby, M. Moustafa, A.L. MacGowan, S.J. Ward and M.J. Cork P22 Malignancies in ustekinumab-treated psoriasis patients: comparisons with the general

U.S. population K. Papp, G.G. Krueger, M.H.A. Rustin, E. Healy, N. Yeilding, P. Szapary, M.C. Hsu, K. Reich, on behalf

of the PHOENIX 1 and PHOENIX 2 Investigators P23 Factors influencing severity of acne D. De and A.J. Kanwar P24 Randomized observer-blinded placebo-controlled study to evaluate the efficacy of

methotrexate plus narrowband ultraviolet (Uv) B phototherapy vs. narrowband UvB phototherapy alone in treatment of chronic plaque-type psoriasis

R. Mahajan, I. Kaur and A.J. Kanwar P25 A retrospective, case cohort study of antitumour necrosis factor therapy in severe

acral psoriasis K. Bhargava, J.N.W.N. Barker and C.E. Smith

Melanoma & Skin CancerP26 Photoprotection education for transplant patients: evaluation of computer-based audio

visual education A. Whyte and A.V. Anstey P27 The incidence of skin cancer detected at a sun-awareness beach campaign C. Morgan, S. Jain, A. Jain and C.J. M. Stephens

P28 Acral lentiginous melanoma of the foot: 37 cases I. Bristow and K.M. Acland

P29 Squamous cell carcinoma on curettage: what happens next? G. Dawn

PO

STER

S

51

P30 how complete are our excision biopsies for skin cancers? I. Palamaras, A. Al-Dulaimi, S. Mansoor, N.S. Murali, P. Thomson, H.P. Stevens and W.S. Robles P31 An audit of cutaneous lymphoma management A. Kedward, K.E. McKenna and M. Walsh P32 Aberrant DNA methylation is linked with MTHFR C677T genetic polymorphism in

cutaneous squamous cell carcinoma M.E. Laing, R. Cummins, E. Kay and G.M. Murphy P33 Positron-emission tomography with computed tomography (PET/CT) in melanoma

follow-up R. Abbott, M. Harries, K.M. Acland and M. O’Doherty P34 Audit of 5% fluorouracil and imiquimod regimes in actinic keratosis and Bowen’s disease

in Scotland compared with current guidelines G. Wylie, B. Shaheen and G. Dawn P35 Deprivation and skin cancer: is there a link? V.R. Doherty, S. Fraser, D. Brewster, S. Jensen and D. Gorman P36 Audit of Scottish dermatologists’ skin cancer surgical excision margins G. Wylie and G. Dawn

P37 Study of operating practices in sunbed parlours in Northern Ireland C. Devereux, A.O. Hagan and A. Gavin

P38 Mohs micrographic surgery for the treatment of basal cell carcinoma: an audit of 5-year follow-up data

N. Cooke, J. McKenna, M. Walsh and O.M. Dolan P39 Acral lentiginous melanoma M.I. Darling, S.A. Ghaffar and V.R. Doherty P40 An audit of sentinel lymph node biopsy use in patients with malignant melanoma A. McKeating, C. Lawlor, D. Evoy, K. Sheahan, J. Crown and B. Kirby

Medical Dermatology and TherapyP41 Surgical excision of skin cancer in New Zealand: how important is the surgeon’s training? N. Mortimer, P. Salmon and S. Hill P42 Assessment of botulinum toxin A for primary axillary hyperhidrosis using a modified

Dermatology Life Quality Index questionnaire M. Chattopadhyay, C. Fuller and R. Morris-Jones P43 Audit of superficial X-ray and Grenz-ray treatment of benign dermatological conditions H.M. Liew and M. Wilkinson P44 The neuropsychiatric phenotype in Darier disease K. Gordon-Smith, N. Craddock, L. Jones and S.M. Burge P45 Mycophenolate mofetil: an audit of its use in dermatology in the U.K. D. Shah and P. Balasubramaniam

P46 Darier–white disease: a follow-up study E. Ormerod, K. Gordon-Smith, N. Craddock, L. Jones and S.M. Burge

P47 Lower limb cellulitis as managed by a dermatology department: 2 years’ experience S.L.P. Chong, C. Wingfield, N.J. Levell and J. Garioch P48 Regression of extensive epidermal naevus in Proteus-like syndrome treated

with rapamycin J. Kluk, C. Moss and N.J. McLellan

52

PO

STER

SP49 Patient-reported multiple drug reactions: clinical profile and results of challenge testing M. Ramam, R. Bhat, S. Jindal, U. Kumar, V. Sharma, R. Sagar and R. Chadda P50 Clinical applicability of T-SPOT.TB screening prior to initiation of antitumour necrosis

factor- therapy N.Y.Z. Chiang, K. Panting and R.A.G. Parslew P51 Botulinum toxin service for axillary hyperhidrosis: patient outcomes E. Ogden, E. Farley and J.K. Schofield P52 Measuring disease severity and damage in discoid lupus erythematosus S. Wahie, N.J. Reynolds, E. McColl and S.J. Meggitt P53 validation of a semiautomated method of minimal phototoxic dose testing O. Al Ofi, C. Edwards and A.V. Anstey P54 Patients with Fabry disease with cutaneous vascular lesions have higher disease severity

scores and more multisystem involvement: data from 1354 patients registered on FOS, the Fabry Outcome Survey

S. Dhoat, C.H. Orteu, C. Navarro, O. Lidove, T. Jansen and J. Clarke P55 Is the development of antinuclear antibodies and antidouble-stranded DNA antibodies on

antitumour necrosis factor treatments a marker of treatment failure in psoriasis? A. Pink, J.N.W.N. Barker and C. Smith

P56 Comparison of azathioprine prescribing practice amongst dermatologists, gastroenterologists and rheumatologists

B. Moran, G.A Doherty, F. Murray P57 Fabry disease and angiokeratoma corporis diffusum are not synonymous: cutaneous

vascular lesions and facial features in 100 patients with Fabry disease C.H. Orteu, A.B. Mehta, S. Dhoat and D.A. Hughes P58 Patients’ experience of hospital and home iontophoresis M.A. McAleer, S. Rogers and P. Collins Case series and cases / CPCsP59 Omalizumab in the treatment of resistant urticarial vasculitis C. Kennedy, B. Moriarty and J. Bourke P60 Self-resolving invasive squamous cell carcinoma or giant keratoacanthoma? M. Shah and L. Green P61 A two-generation family with ChILD syndrome: a 20-year follow-up A.B. Alexandroff, A. Kinning, M. Bamford, K.H. Grzeschik, A. Milligan, R.D.R. Camp P62 Myotonic dystrophy and basal cell carcinomas: coincidence or true association? S. Goolamali, E. Edmonds, N. Francis and C. Bunker

P63 Sorafenib-induced erythema multiforme K.D. Gordon and E.M. Wain P64 vulval hyperpigmentation S. Goolamali, F. Lewis, E. Calonje and S. Neill

P65 The prevalence of dermatological disease in older people of different ethnicity in a secondary care setting

P. Rakvit and E. Mallon P66 Superficial granulomatous pyoderma of the vulva in a patient receiving maintenance

rituximab for non-hodgkin lymphoma M. Walsh, N. Leonard and H. Bell P67 An unusual cutaneous complication of BCG immunotherapy A. Lloyd-Lavery, I. Ali, O. Espinosa, B. Angus and R.J. Turner

PO

STER

S

53

P68 The effects of oral acitretin therapy in four children with Papillon–Lefèvre syndrome D. Koch, S. McKaig, I.L.C. Chapple and C. Moss P69 Clinicoepidemiological profile of histoid leprosy from India A.J. Kanwar P70 Cutaneous features associated with undifferentiated connective tissue disease V. Sherman, P. Gordon and J.D. Creamer P71 Resolution of sarcoidosis postmanagement of melanoma A. Lally, A. Pay and L.A. Fearfield P72 Lymphomatoid papulosis associated with etanercept S.L. Chua, K. Kulkarni, S. O’Connor and R. Murphy P73 Rabies: an unusual request for a skin biopsy L. Todd, C. Devereux, R. Corbett and S. Hoey P74 Cutaneous Rosai–Dorfman disease D. Herath and A.P. Harrison P75 Mucosal involvement in vitiligo: a study of 241 patients A.J. Kanwar P76 Two novel CyLD mutations associated with Brooke–Spiegler syndrome N. Rajan, H. Powell, J.A.A. Langtry, A. Carmichael, D. Bourn and J. Burn P77 Multiple basal cell carcinomas following bone marrow transplant and irradiation for

myelodysplasia and underlying monosomy 7 S.J. Fraser, M.I. Darling, J.R. Goodlad and D. Kemmett P78 Relapsed T-cell acute lymphoblastic leukaemia presenting as aleukaemic leukaemia cutis N. Desai, A. Attygale and P.S. Mortimer P79 Cutaneous graft-versus-host disease: the increasing trend of the eczematoid subtype E. Craythorne, E. Benton, G. Mufti and A.W.P. du Vivier P80 Resistant hidradenitis suppurativa treated with adalimumab B. Moran, S.C.F. Rogers and B. Kirby P81 Primary cutaneous peripheral T-cell lymphoma, unspecified, with an indolent clinical

course: a distinct peripheral T-cell lymphoma? A. Ryan, B. Hayes, A. Robson, K. Sheahan and P. Collins

P82 Epstein–Barr virus-associated cutaneous CD30+ B-cell lymphoma related to azathioprine therapy for dermatomyositis

M.A. McAleer, C.A. D’Arcy, N.J. Mulligan, K. Sheahan and P. Collins P83 Proportion of regulatory T cells in the cutaneous infiltrate of 27 patients with mycosis

fungoides: a retrospective case series S. Bakis-Petsoglou, S.J. Whittaker and S.Y. Tan

Education and TrainingP84 Chronic skin diseases influence major life-changing decisions: a new frontier in health

outcome research Z.U. Bhatti, A.Y. Finlay and S. Salek P85 Nonclinical influences on clinical decision making in dermatology F. Hajjaj, M.K. Basra, S. Salek and A.Y. Finlay P86 On-line dermatology teaching: a cross-sectional survey of the impact of an emerging

pedagogy in dermatology M.K.A. Basra, S. Coxall and M. Gonzalez

P87 Audit of registrar-structured teaching in Scotland G. Wylie and G. Dawn

54

PO

STER

SP88 The virtual Patient: a novel tool to supplement the teaching of psoriasis to

undergraduate medical students J. Vyas and M. Gonzalez Service IssuesP89 Audit of histopathology request forms for cutaneous lesions comparing a large

dermatology department with regional general practices T. Gunson, W. Farrar and N. Wilson P90 Audit of on-call referrals to the dermatology service in a U.K. teaching hospital S.H.M.A. Basar, S. Gupta, S. Crichlow, A.B. Alexandroff, G.E. Elston, R.F Davies, J. Shah,

N. Ali and I. Helbling P91 Dermatology in the community: are the guidelines being followed? M. Walsh and C. King P92 The paperless dermatology service: a unique opportunity for computerization K.D. Davies and C.P.R. Bower P93 A new model of acute-care delivery: the role of the consultant dermatologist D. Sandhu, F. Tatnall, M. Murdoch and K. Batta P94 Failure of adherence to NICE guidelines for skin cancer surgery in general practice E.J. Carter, L.R. Whittam and D.A. Buckley P95 Use of chaperones in the dermatology department for intimate examinations: cross-

sectional survey of practices of dermatologists F. Ismail, A. Bewley and V. Jolliffe P96 A review of procedures carried out on basal cell carcinomas by primary care physicians R. Gait, A. Milligan, R.M. Burd and A. Fletcher P97 Basal cell carcinomas: impact of national guidance on local specialist dermatology

department is likely to be manageable S. Anthony, E. Ogden, M. Blanshard and J.K. Schofield

P98 Choose and Book: dermatology patients’ views and its impact on delivering dermatology outpatient care

S. Gupta, L. Kilmartin, J. Ragwani, A. Alexandrov and G.A. Johnston P99 Skin disease consultations in a general practice E.Y.L. Yap, J.C. Sterling and M. Bamford P100 The impact of cancer waiting time targets for melanoma S.A. Ghaffar, M.I. Darling and V.R. Doherty P101 Paediatric ward referrals to dermatology: a regional audit K. Panting and T. Clayton P102 An audit of the implementation of a policy of not accepting GP referrals of benign

cosmetic skin lesions C. Devereux and D.J. Eedy P103 Nonconsultant career grade dermatologists in the U.K. H.M. Horn P104 Are patients happy to be informed of their final skin cancer results by post? P. Thomson, I. Palamaras, V. Hill, W.S. Robles and H.P. Stevens historical PosterP105 The light that changed the world P.D. Yesudian P106 Alan Lyell (1917–2007) and the birth of toxic epidermal necrolysis M.A. Porter, C. May and C.S. Munro

SAT

ELITT

E SyM

PO

SIUM

55

TUESDAy JULy 7Th – SATELLITE SyMPOSIUM TIME PROGRAMME vENUE

17:30 – 18:30 LEO PhARMA SATELLITE SyMPOSIA DOChART

Psoriasis Combination Therapy on Trial LEO Pharma will be holding a very special satellite symposium at the 89th Annual

meeting of the British Association of Dermatologists/19th Annual meeting of the British Dermatological Nursing Group.

The Dochart room will be transformed into a live courtroom for the hour-long trial that will be presided over by our very own ‘Judge’, Professor Rino Cerio.

Prosecuting the case against combination therapy in the treatment of psoriasis will be Dr. Colin Fleming.

Dr. Sandeep Cliff will be acting for the defence, in support of combination therapy.

Both counsels will be inviting witnesses who will give accounts of their experience with combination treatments and scientific evidence will be exhibited for and against.

Also present will be 12 dermatological members of the jury, who will collectively decide the outcome of the trial.

Please come along to witness this ‘first’ amongst dermatological symposia!

How will they find the defendant guilty or not guilty?

wEDNESDAy JULy 8Th – SATELLITE SyMPOSIUM TIME PROGRAMME vENUE 13:00 – 14:00 JANSSEN – CILAG LTD SATELLITE SyMPOSIA FORTh

From Research to Reality:

Biologics in the Treatment of Moderate to Severe Psoriasis Chair: Prof. Jonathan Barker, Professor of Dermatology,

St John’s Institute of Dermatology, London Biologics in Practice:

Results from a Treatment Pathway and Resource Utilisation Study Dr Catherine Smith, Consultant Dermatologist,

St John’s Institute of Dermatology, London New targets in psoriasis: Ustekinumab & IL12/IL 23 blockade Dr Jacqueline Benson, Director Immunology Research & Development, Centocor, USA ACCEPT - ustekinumab vs etanercept in the treatment of moderate to

severe psoriasis Prof. Christopher Griffiths, Foundation Professor of Dermatology, University of

Manchester, Manchester

56

SAT

ELIT

TE

SyM

PO

SIU

M TIME PROGRAMME vENUE 13:00 – 14:00 ABBOTT SATELLITE SyMPOSIA CARRON

Confidence in long-term biologic use; Practical Considerations in moderate-severe chronic plaque psoriasis Chair: Dr David Burden, Western Infirmary, Glasgow, UK welcome and Introduction Dr David Burden Western Infirmary, Glasgow, UK Biologic therapy: presenting the long-term evidence in moderate-severe

chronic plaque psoriasis Prof. Richard Langley Dalhousie University, Canada Prescribing biologics long term: practical considerations Dr Richard Warren University of Manchester, UK Questions and closing comments CPD approved 13:00 – 14:00 STIEFEL LABORATORIES UK LTD SATELLITE SyMPOSIA LOMOND AUDITORIUM

A review of recent advances in the field of atopic dermatitis Chair: Prof. John Harper 13:00 Introduction Skin barrier atopic eczema and allergy Prof. John Harper London 13:10 Treatment strategies in the management of atopic eczema that produce

the best repair of the defective skin barrier Prof. Mike Cork Sheffield 13:25 why Treatments fail in Atopic eczema and what can we do about it Dr Sue Lewis Jones Dundee 13:40 New patient initiatives and the role of education in the management of

atopic eczema Margaret Cox (NES)

London 13:50 Questions for the panel All 14:00 Close

SAT

ELITT

E SyM

PO

SIUM

57

TIME PROGRAMME vENUE 18:00 – 19:00 SChERING-PLOUGh SATELLITE SyMPOSIA FORTh

Psoriasis: Inside and out Moderator: Alan Hansen From deep within – psoriasis beyond the skin Prof. Jonathan Barker, St John’s Institute of Dermatology, London Rising to the challenge – the link between psoriasis and arthritis Prof. Dennis McGonagle University of Leeds, Leeds Going beyond – redefining total clearance Prof. Kristian Reich Dermatologikum Hamburg, Germany Close

ThURSDAy JULy 9Th – SATELLITE SyMPOSIUM TIME PROGRAMME vENUE 17:30 – 18:30 ASTELLAS PhARMA SATELLITE SyMPOSIA FORTh

Twice weekly Protopic: A New way of Keeping Moderate and Severe Atopic Dermatitis Patients

Flare-Free for Longer Chair: TBC Epidermal Barrier – Broken Defences Prof. Mike Cork Sheffield Subclinical Inflammation: what Lies Beneath TBC The Clinical Evidence for a New Approach TBC Close

58

MA

P O

F G

LASG

Ow

A

B

C

A

B

C

Sc

ott

ish

Ex

hib

itio

n &

Co

nfe

re

nc

e C

en

tre

Th

e S

co

ttis

h E

xh

ibit

ion

& C

on

fere

nce

Ce

ntr

e

Gla

sg

ow

Scie

nce

Ce

ntr

e

Ke

lvin

gro

ve

Mu

se

um

MAP OF GLASGOw

AUGUST 2009 Learning, Teaching and Assessment

Venue: Lady Margaret Hall, Oxford

Date: 27th – 28th August 2009

SEPTEMBER 2009 SpR Training Event

Venue: BAD House

Date: 24th - 25th September 2009

OCTOBER 2009 Clinical Dermatology Update Meeting for Staff and Associate Specialist Doctors

Venue: Radisson SAS Manchester

Date: 1st - 2nd October 2009

NOvEMBER 2009 Digital workshop

Venue: BAD House, London

Date: 12th November 2009

UK Dermatology Course for Consultants

Venue: Radisson Hotel, Manchester

Date: 27th - 28th November 2009

CES MEETINGS CALENDAR

For Further Details on any of these meetings please contact: • Conference & Event Services;

4 Fitzroy Square London w1T 5hQ

• Email: conference@bad.org.uk

• Tel: 020 7391 6358

CES M

EETIN

GS C

ALEN

DER

59

60

NO

TES

NO

TES

61

62

NO

TES

Swing for Skin Golf Day at the Belfry

Friday 18th September 2009

Fancy a round of golf? The British Skin Foundation is looking for keen individuals who like the idea of swinging for a great cause.

Swing for Skin is an exciting new event in the BSF calendar. Participants

will be able to play at the world renowned Belfry golf course in the West Midlands, and at £199 per individual or £749 for a team of four, this is a

fantastic way to raise money for the only charity in the UK dedicated to raising funds for skin disease research.

The driving range, and play at the 18 holes of golf on the Brabazon

course are included in the price as is buffet dinner with wine in the evening. Additional diners are more than welcome to come along at a

very reasonable £26.95.

There will also be complimentary longest drive and nearest the pin competitions on the day. The event promises to be a huge amount of fun

and a fantastic competition. Sign up now, spaces are limited!

Start time: 9.30 – 11.30 (depending on tee off time)

To register, or for more information, call the BSF events team on 0207 391 6352 or email bsfevents@bad.org.uk

London to Paris Bike

Ride 2009

30th September – 4th October 2009

Fancy a challenge? Cycle in aid of the British Skin Foundation in

this year’s London to Paris Bike Ride.

It’s a hugely rewarding cycling experience that sees you pass

through the Kent countryside, across the Channel and through small picturesque villages in Northern France. You’ll cycle well

over 300 miles over the five days, and finish at the Eiffel Tower.

Bring with you a sense of adventure, a good team spirit and prepare for some challenging hill climbs, this is the perfect way to

raise money for the only charity dedicated to raising funds for

skin disease research.

To register or for more information, call the BSF events team

on 0207 391 6352 or email bsfevents@bad.org.uk